{
  "meta": {
    "title": "00460_Late_Night_Pyq_Pyt_Medicine-4",
    "url": "https://brainandscalpel.vercel.app/00460-late-night-pyq-pyt-medicine-4-4f51bc68.html",
    "scrapedAt": "2025-11-29T18:10:02.127Z"
  },
  "questions": [
    {
      "id": 74885,
      "choices": [
        {
          "id": 298437,
          "text": "<p><span style=\"font-size:16px;\">Fungal hyphae surrounded by lymphocytes</span></p>"
        },
        {
          "id": 298438,
          "text": "<p><span style=\"font-size:16px;\">Anthracosis pigment</span></p>"
        },
        {
          "id": 298439,
          "text": "<p><span style=\"font-size:16px;\">Necrotizing epithelioid granuloma</span></p>"
        },
        {
          "id": 298440,
          "text": "<p><span style=\"font-size:16px;\">Reactive hyperplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 30-year-old woman presents with weight loss, mediastinal lymphadenopathy, and pleural effusion. Her HRCT shows a \"tree-in-bud\" pattern, indicating lung consolidation and effusion. Analysis of pleural fluid reveals high adenosine deaminase (ADA) levels with a predominance of lymphocytes. What is the most likely finding on lymph node biopsy? (INICET NOV 2024)</span></p>",
      "unique_key": "Q8738829",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012854,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Necrotizing epithelioid granuloma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This is a classic presentation of tuberculosis (TB):</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">\"Tree-in-bud\" appearance on HRCT indicates endobronchial spread — a hallmark of active pulmonary TB.</span></li><li><span style=\"font-size:16px;\">Mediastinal lymphadenopathy and pleural effusion with lymphocyte predominance further support a tuberculous etiology.</span></li><li><span style=\"font-size:16px;\">High ADA (&gt;40 U/L) in pleural fluid is a strong indicator of TB pleuritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">The most characteristic lymph node biopsy finding in TB is:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Necrotizing (caseating) epithelioid granulomas</strong></span></li><li><span style=\"font-size:16px;\">&nbsp;Composed of epithelioid cells (from activated macrophages), Langhans giant cells, and central caseous necrosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Fungal hyphae surrounded by lymphocytes:</strong> &nbsp;Seen in invasive fungal infections (e.g., aspergillosis, histoplasmosis), more common in immunocompromised individuals; not typically associated with high ADA.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Anthracosis pigment:</strong> Black carbon pigment in lungs/lymph nodes from pollution or smoking. Not pathological in itself and doesn’t cause systemic symptoms or effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Reactive hyperplasia:</strong> Seen in viral or nonspecific bacterial infections. No granulomas or caseation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In a young woman with systemic symptoms, tree-in-bud pattern, lymphocytic pleural effusion, and high ADA, TB is the most likely diagnosis. The hallmark histopathological finding is a necrotizing epithelioid granuloma.</span></p>",
      "correct_choice_id": 298439,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16295,
      "choices": [
        {
          "id": 65140,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cefotaxime</span></span></span></p>"
        },
        {
          "id": 65141,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Metronidazole</span></span></span></p>"
        },
        {
          "id": 65142,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Amoxicillin</span></span></span></p>"
        },
        {
          "id": 65143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vancomycin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old chronic alcoholic is brought to the hospital due to fever and abdominal pain. He was diagnosed to have a cirrhotic liver 2 years back. The ascitic fluid shows a neutrophil count of 360 cells/microliter. Which of the following is the drug of choice in this patient?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(FMGE DEC 2021)</span></span></span></p>",
      "unique_key": "Q7777240",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012769,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Cefotaxime</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient likely has spontaneous bacterial peritonitis (SBP), a common and serious complication of cirrhosis, characterized by an infection of the ascitic fluid. A neutrophil count of 360 cells/microliter in ascitic fluid confirms SBP. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cefotaxime or ceftriaxone, a third-generation cephalosporin, is the drug of choice because it is effective against most of the bacteria that cause SBP. However, the ICMR guidelines recommend using Peptazo (piperacillin-tazobactam) in India due to high levels of resistance to third-generation cephalosporins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Metronidazole</span></strong><span style=\"font-size:12.0pt\">: Effective for anaerobic infections but not the first choice for SBP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Amoxicillin</span></strong><span style=\"font-size:12.0pt\">: Not as effective as cefotaxime for the organisms commonly causing SBP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Vancomycin</span></strong><span style=\"font-size:12.0pt\">: Used for Gram-positive infections but not typically for SBP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cefotaxime is the preferred treatment for spontaneous bacterial peritonitis in cirrhotic patients.</span></span></span></p>",
      "correct_choice_id": 65140,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11566,
      "choices": [
        {
          "id": 46230,
          "text": "<p><span style=\"font-size:12.0pt;\">CT angiography to look for large vessel occlusion</span></p>"
        },
        {
          "id": 46231,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI to look for infarct</span></p>"
        },
        {
          "id": 46232,
          "text": "<p><span style=\"font-size:12.0pt;\">Tab labetalol 10 mg stat</span></p>"
        },
        {
          "id": 46233,
          "text": "<p><span style=\"font-size:12.0pt;\">Thrombolysis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man suddenly developed right-sided weakness and aphasia within 2 hours. His BP recorded was 160/110 mmHg and NCCT was clear. What is the next step in management? (INICET MAY 2021)</span></p>",
      "unique_key": "Q1284812",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012861,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;D) Thrombolysis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">With a BP below 185/110 mmHg, clear NCCT, and symptoms within 4.5 hours, the patient qualifies for thrombolysis, the standard treatment for acute ischemic stroke to dissolve clots and restore blood flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">If the blood pressure (BP) is more than or equal to 185/110 mmHg, administer IV labetalol to lower the BP to less than 185/110 mmHg before immediately proceeding with thrombolysis. CT angiography can be performed while thrombolysis is ongoing. Start the thrombolytic agent in the CT room and simultaneously inject a bolus of contrast for the CT angiogram to check for large vessel occlusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. CT angiography:&nbsp;</strong>CT angiography can be done simultaneously with thrombolysis but not instead of it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. MRI:&nbsp;</strong>MRI is not the immediate next step when NCCT is clear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Labetalol:&nbsp;</strong>Labetalol is used to lower BP but not the primary treatment in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12pt;\">In acute ischemic stroke with BP &lt; 185/110 and clear NCCT, thrombolysis is the next step.</span></p>",
      "correct_choice_id": 46233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16179,
      "choices": [
        {
          "id": 64676,
          "text": "<p><span style=\"font-size:12.0pt;\">Small-cell lung cancer</span></p>"
        },
        {
          "id": 64677,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal tumor</span></p>"
        },
        {
          "id": 64678,
          "text": "<p><span style=\"font-size:12.0pt;\">Ectopic ACTH syndrome</span></p>"
        },
        {
          "id": 64679,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary microadenoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most common cause of Cushing's disease in a 60-year-old male is: (FMGE JAN 2023)</span></p>",
      "unique_key": "Q2079449",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012797,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;<strong>D) Pituitary microadenoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cushing's disease is specifically caused by a pituitary adenoma that secretes excess adrenocorticotropic hormone (ACTH). This excess ACTH stimulates the adrenal glands to produce more cortisol, leading to the symptoms of Cushing's syndrome. In the context of Cushing's disease, the term always refers to a pituitary origin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cushing's syndrome, on the other hand, can have various causes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Exogenous Cushing's syndrome:</strong> Due to external sources of cortisol, such as prolonged use of glucocorticoid medications.</span></li><li><span style=\"font-size:12pt;\"><strong>Endogenous Cushing's syndrome:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12pt;\">subdivided into –&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">ACTH-dependent - High ACTH levels stimulate cortisol production, associated with symptoms like hyperpigmentation.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12pt;\">(e.g.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12pt;\">pituitary adenoma/ cushing’s disease, ectopic ACTH secretion)</span></li><li><span style=\"font-size:12pt;\">ACTH-independent - Low or normal ACTH levels, with cortisol overproduction directly from the adrenal glands (e.g., adrenal adenoma, adrenal carcinoma).</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Among the endogenous causes, pituitary adenomas (Cushing's disease) are the most common, responsible for about 60-65% of cases. Ectopic ACTH secretion accounts for about 20-25% of cases, and adrenal tumors are responsible for 5-10% of cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Small-cell lung cancer:</strong> Can cause ectopic ACTH syndrome but is not the most common cause of Cushing's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Adrenal tumor:</strong> Can cause Cushing's syndrome but is less common compared to pituitary adenomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Ectopic ACTH syndrome:</strong> Can be caused by various tumors, including small-cell lung cancer, but is not as common as pituitary adenomas in causing Cushing's disease.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pituitary microadenoma is the most common cause of Cushing's disease, which is characterized by excess ACTH production from the pituitary gland.</span></p>",
      "correct_choice_id": 64679,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73070,
      "choices": [
        {
          "id": 291245,
          "text": "<p><span style=\"font-size:16px;\">Chronic obstructive pulmonary disease (COPD)</span></p>"
        },
        {
          "id": 291246,
          "text": "<p><span style=\"font-size:16px;\">Pulmonary fibrosis</span></p>"
        },
        {
          "id": 291247,
          "text": "<p><span style=\"font-size:16px;\">Interstitial lung disease (ILD)</span></p>"
        },
        {
          "id": 291248,
          "text": "<p><span style=\"font-size:16px;\">Asthma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 55-year-old male smoker presents with a history of progressive dyspnea and chronic cough. Pulmonary function tests (PFTs) reveal the following: (FMGE JAN 2025)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Decreased FEV₁</span></li><li><span style=\"font-size:16px;\">Decreased FEV₁/FVC ratio (&lt;70%)</span></li><li><span style=\"font-size:16px;\">Minimal improvement in FEV₁ after bronchodilator therapy</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">What is the most likely diagnosis?</span></p>",
      "unique_key": "Q9530622",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012775,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Chronic obstructive pulmonary disease (COPD)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This case presents a <strong>classic presentation of COPD</strong> with the following diagnostic features:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>History of smoking</strong> (major risk factor)</span></li><li><span style=\"font-size:16px;\"><strong>Progressive dyspnea and chronic cough</strong> (typical symptoms)</span></li><li><span style=\"font-size:16px;\"><strong>PFT findings:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>Decreased FEV₁ and FEV₁/FVC ratio &lt;70%</strong> (diagnostic of obstructive airway disease)</span></li><li><span style=\"font-size:16px;\"><strong>Fixed obstruction with minimal bronchodilator response</strong> (<strong>distinguishing it from asthma, which shows significant bronchodilator response</strong>)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">According to the <strong>GOLD criteria</strong>, a <strong>post-bronchodilator FEV₁/FVC ratio &lt;70% confirms COPD</strong> in patients with appropriate symptoms and risk factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Pulmonary fibrosis:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Shows a <strong>restrictive pattern on PFTs</strong> with <strong>FEV₁/FVC &gt;70%</strong> and <strong>reduced total lung capacity (TLC)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Interstitial lung disease (ILD):</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">ILD also shows a <strong>restrictive pattern</strong>, not <strong>obstruction</strong></span></li><li><span style=\"font-size:16px;\">Would present with <strong>decreased lung volumes and preserved FEV₁/FVC ratio</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Asthma:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Asthma can show <strong>decreased FEV₁ and FEV₁/FVC ratio</strong>, but it typically demonstrates <strong>significant bronchodilator reversibility (&gt;12% and &gt;200 mL improvement in FEV₁)</strong>, which is <strong>not seen in this case</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">COPD is diagnosed by a <strong>post-bronchodilator FEV₁/FVC ratio &lt;70%</strong>, minimal bronchodilator response, and <strong>risk factors such as smoking</strong>.</span></p>",
      "correct_choice_id": 291245,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73070/FMGE_Jan_2025_Medicine_Q_-_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73070/FMGE_Jan_2025_Medicine_Q_-_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11840,
      "choices": [
        {
          "id": 47326,
          "text": "<p><span style=\"font-size:12.0pt;\">Right Ventricle</span></p>"
        },
        {
          "id": 47327,
          "text": "<p><span style=\"font-size:12.0pt;\">Left Ventricle</span></p>"
        },
        {
          "id": 47328,
          "text": "<p><span style=\"font-size:12.0pt;\">Aorta</span></p>"
        },
        {
          "id": 47329,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral Valve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A chronic smoker presented with shortness of breath, bilateral pitting pedal edema, and abdominal distension. On examination, jugular venous pulse was found to be elevated and liver was palpable 8 cm below the costal margin. An abnormality in which of the following structures is responsible for the patient's symptoms? (INICET NOV 2021)</span></p>",
      "unique_key": "Q6078608",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012860,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Right Ventricle</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient’s presentation is characteristic of <strong>right ventricular failure</strong>, often secondary to chronic obstructive pulmonary disease (COPD) in chronic smokers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key clinical features include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Shortness of breath</strong>: A common symptom in both left and right heart failure but is notably worsened by right heart failure due to fluid overload.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Bilateral pitting pedal edema</strong>: Indicates fluid retention, a hallmark of right ventricular failure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Abdominal distension</strong>: Often due to ascites, which is related to increased venous pressure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Elevated jugular venous pulse (JVP)</strong>: Reflects increased central venous pressure due to right heart dysfunction.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hepatomegaly (enlarged liver)</strong>: Due to congestion of blood in the liver secondary to increased venous pressure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Right ventricular failure results from the right ventricle's inability to pump blood effectively to the lungs, leading to a backup of blood in the systemic venous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Left Ventricle</strong>: Left ventricular failure primarily causes pulmonary congestion and edema due to the backflow of blood into the lungs. Symptoms like shortness of breath would predominate without the systemic venous congestion (e.g., pedal edema, elevated JVP, hepatomegaly) seen in right ventricular failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aorta</strong>: An aortic abnormality would not directly cause the combination of symptoms described. Issues with the aorta generally result in systemic hypertension, aortic aneurysm, or dissection, which have different clinical presentations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mitral Valve</strong>: Mitral valve disease, particularly mitral stenosis or regurgitation, primarily affects the left atrium and ventricle, leading to pulmonary congestion and symptoms more indicative of left heart failure rather than the systemic congestion seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Right ventricular failure</strong> is characterized by systemic venous congestion, which manifests as elevated jugular venous pressure, pitting pedal edema, hepatomegaly, and abdominal distension. This condition is often seen in chronic smokers due to the impact of chronic obstructive pulmonary disease (COPD) on the heart.</span></p>",
      "correct_choice_id": 47326,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47607,
      "choices": [
        {
          "id": 190039,
          "text": "<p><span style=\"font-size:12.0pt;\">TIA</span></p>"
        },
        {
          "id": 190040,
          "text": "<p><span style=\"font-size:12.0pt;\">Thrombo-embolic stroke</span></p>"
        },
        {
          "id": 190041,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardio-embolic stroke</span></p>"
        },
        {
          "id": 190042,
          "text": "<p><span style=\"font-size:12.0pt;\">Paradoxical embolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old lady develops sudden onset facial deviation with slurring of speech and inability to raise right arm. The symptoms spontaneously begin to reduce and has significant improvement over the next 48 hours. She has a mid-diastolic murmur on auscultation and irregular heart rhythm. What is the diagnosis?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q2388240",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012799,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Cardio-embolic stroke</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with sudden onset neurological deficits (facial deviation, slurred speech, and right arm weakness), which improved significantly over 48 hours. The presence of a mid-diastolic murmur suggests mitral stenosis, and the irregular heart rhythm indicates atrial fibrillation. These are strong risk factors for cardio-embolic stroke. Although the improvement suggests a transient ischemic attack (TIA), the symptoms lasted more than 24 hours, which aligns with the definition of a stroke rather than a TIA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. TIA:&nbsp;</strong>By definition, a TIA's symptoms resolve <strong>within 24 hours.</strong> Since the symptoms persisted for more than 24 hours, this is not a TIA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Thrombo-embolic stroke:&nbsp;</strong>While possible, the presence of mitral stenosis and atrial fibrillation makes cardio-embolic stroke more likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Paradoxical embolism:&nbsp;</strong>This occurs when a thrombus from the venous system passes through a right-to-left cardiac shunt (e.g., patent foramen ovale) into the arterial system. There is no mention of such a shunt or a history of deep vein thrombosis (DVT) in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cardio-embolic stroke should be suspected in patients with sudden onset neurological deficits and risk factors such as mitral stenosis and atrial fibrillation. Symptoms persisting for more than 24 hours distinguish stroke from TIA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-092628.png\" alt=\"\" width=\"600\" height=\"568\"></span></p>",
      "correct_choice_id": 190041,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73071,
      "choices": [
        {
          "id": 291249,
          "text": "<p><span style=\"font-size:16px;\">Pleural effusion</span></p>"
        },
        {
          "id": 291250,
          "text": "<p><span style=\"font-size:16px;\">Pulmonary fibrosis</span></p>"
        },
        {
          "id": 291251,
          "text": "<p><span style=\"font-size:16px;\">Pulmonary edema</span></p>"
        },
        {
          "id": 291252,
          "text": "<p><span style=\"font-size:16px;\">Hydrothorax</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the X-ray shown below. (FMGE JAN 2025)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_HJbVSzM.png\" width=\"289\" height=\"306\"></span></p>",
      "unique_key": "Q5056068",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012801,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Pulmonary edema</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The <strong>chest X-ray</strong> demonstrates the <strong>classic \"bat wing\" appearance</strong> characteristic of <strong>pulmonary edema</strong>. This pattern shows:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Bilateral hilar infiltrates with a perihilar distribution</strong></span></li><li><span style=\"font-size:16px;\"><strong>Butterfly or bat-wing-shaped opacity</strong></span></li><li><span style=\"font-size:16px;\"><strong>Edema fluid accumulation in the interstitial and alveolar spaces</strong> due to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>Increased hydrostatic pressure in the pulmonary circulation (e.g., left heart failure)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Increased capillary permeability</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Pleural effusion:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Typically shows <strong>blunting of the costophrenic angles with a meniscus sign</strong></span></li><li><span style=\"font-size:16px;\">The pattern seen here is <strong>more central and perihilar</strong>, rather than at the <strong>lung bases</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Pulmonary fibrosis:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Pulmonary fibrosis shows <strong>reticular opacities, honeycombing, and traction bronchiectasis</strong></span></li><li><span style=\"font-size:16px;\">The pattern is usually <strong>peripheral and basal</strong>, not <strong>central and perihilar</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Hydrothorax:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">A <strong>pleural effusion containing transudative fluid</strong></span></li><li><span style=\"font-size:16px;\">Would show a <strong>meniscus sign and blunting of costophrenic angles</strong>, rather than a <strong>central bat-wing distribution</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Recognize the <strong>classic \"bat wing\" or \"butterfly\" pattern on chest X-ray</strong> as characteristic of <strong>pulmonary edema</strong>, which presents as <strong>bilateral perihilar infiltrates with a central distribution</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_pcODZlz.png\" width=\"857\" height=\"354\"></span></p>",
      "correct_choice_id": 291251,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73071/FMGE_Jan_2025_Medicine_Q_-_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73071/FMGE_Jan_2025_Medicine_Q_-_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11620,
      "choices": [
        {
          "id": 46446,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcified valve</span></p>"
        },
        {
          "id": 46447,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic regurgitation</span></p>"
        },
        {
          "id": 46448,
          "text": "<p><span style=\"font-size:12.0pt;\">First degree heart block</span></p>"
        },
        {
          "id": 46449,
          "text": "<p><span style=\"font-size:12.0pt;\">Mild mitral stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The absence of loud S1 in mitral stenosis would indicate all of the following, except:</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q9445488",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012782,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Mild mitral stenosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The first heart sound (S1) is produced by the closure of the mitral and tricuspid valves at the beginning of systole. In mitral stenosis, the loudness of S1 can vary depending on several factors. A loud S1 is typically associated with the early stages of mitral stenosis when the valve leaflets are still relatively mobile. However, in certain conditions, S1 can become softer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In mild mitral stenosis without significant calcification usually results in a loud S1. This is because the mitral valve leaflets are still relatively mobile and can close forcefully. Therefore, mild mitral stenosis is the correct exception in this context, as it does not typically cause a soft S1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Calcified valve:</strong> When the mitral valve becomes calcified, it loses its mobility. This results in a softer S1 because the valve leaflets are not able to close rapidly or forcefully.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Aortic regurgitation:</strong> Aortic regurgitation can lead to an increased preload in the left ventricle, which can in turn affect the closure of the mitral valve, making S1 softer. Additionally, mitral regurgitation, which often coexists with mitral stenosis, can also soften S1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. First degree heart block:</strong> In first degree AV block, there is a prolonged PR interval. This delayed conduction can lead to a less forceful closure of the mitral valve, resulting in a softer S1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In mitral stenosis, a loud S1 is typically seen in the early stages with mobile valves, while a soft S1 can indicate valve calcification, aortic regurgitation, or first degree heart block. Mild mitral stenosis without calcification usually results in a loud S1</span></p>",
      "correct_choice_id": 46449,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11891,
      "choices": [
        {
          "id": 47529,
          "text": "<p><span style=\"font-size:12.0pt;\">Glimepiride</span></p>"
        },
        {
          "id": 47530,
          "text": "<p><span style=\"font-size:12.0pt;\">Exenatide</span></p>"
        },
        {
          "id": 47531,
          "text": "<p><span style=\"font-size:12.0pt;\">Vildagliptin</span></p>"
        },
        {
          "id": 47532,
          "text": "<p><span style=\"font-size:12.0pt;\">Linagliptin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with diabetes, hypertension, and chronic kidney disease has elevated serum creatinine and urea levels. Which of the following oral hypoglycemic agents is safe to use? (INICET NOV 2022)</span></p>",
      "unique_key": "Q9222152",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012858,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Linagliptin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with chronic kidney disease (CKD) require careful selection of hypoglycemic agents due to altered drug excretion and the risk of further renal impairment. Among the given options, linagliptin is the safest choice for such patients. Linagliptin is a DPP-4 inhibitor that does not require dose adjustment in patients with renal impairment, including those on hemodialysis. This is because linagliptin is primarily excreted via the liver rather than the kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note –</strong> Certain GLP-1 receptor agonists like liraglutide, dulaglutide, and semaglutide can be used without dose adjustment according to the latest studies. Additionally, pioglitazone can also be used without dose adjustment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Glimepiride:</strong> This sulfonylurea can cause hypoglycemia and requires dose adjustment in patients with renal impairment, making it less suitable for those with elevated serum creatinine and urea levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Exenatide:</strong> This GLP-1 receptor agonist is contraindicated in patients with severe renal impairment (creatinine clearance &lt;30 mL/min) due to the risk of accumulation and potential toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vildagliptin:</strong> Another DPP-4 inhibitor, vildagliptin requires dose adjustment in renal impairment, making it less favorable compared to linagliptin for patients with CKD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Linagliptin is the preferred oral hypoglycemic agent for patients with diabetes and chronic kidney disease, as it does not require dose adjustment and is safely excreted by the liver.</span></p><p>&nbsp;</p>",
      "correct_choice_id": 47532,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16438,
      "choices": [
        {
          "id": 65712,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dubin-Johnson syndrome</span></span></p>"
        },
        {
          "id": 65713,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crigler-Najjar type 1 syndrome</span></span></p>"
        },
        {
          "id": 65714,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gilbert syndrome</span></span></p>"
        },
        {
          "id": 65715,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rotor syndrome</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 20-year-old male presented with a 1-week history of yellow skin and sclera but is otherwise asymptomatic. He gives a history of viral infection 10 days ago which resolved 2 days back. There is a history of a similar episode of icterus 2 years back when the patient had long hours of basketball practice. The current serum bilirubin is 2.4 mg/dL, unconjugated bilirubin is 2.1 mg/dL, and conjugated bilirubin is 0.3 mg/dL. Serum AST and ALT levels are normal. Which of the following is the most likely diagnosis? (FMGE JUNE 2022)</span></span></span></p>",
      "unique_key": "Q6445296",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012770,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Gilbert syndrome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gilbert syndrome is a common, benign condition characterized by mild unconjugated hyperbilirubinemia. It often presents during times of stress, such as illness or strenuous exercise. Normal liver enzyme levels (AST and ALT) and the presence of predominantly unconjugated bilirubin support this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note - Gilbert syndrome is often discovered incidentally during routine tests. Because bilirubin levels in Gilbert syndrome do not exceed 3 milligrams per decilitre. The condition involves a mild deficiency of the UDP-glucuronyl transferase enzyme, specifically UGT1A1, which is responsible for the conjugation of bilirubin in the liver.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Dubin-Johnson syndrome:</span></strong><span style=\"font-size:12.0pt\"> Causes conjugated hyperbilirubinemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Crigler-Najjar type 1 syndrome:</span></strong><span style=\"font-size:12.0pt\"> Causes severe unconjugated hyperbilirubinemia from birth due to complete deficiency of the UGT1A1 enzyme, often leading to kernicterus. Highly fatal disease. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Rotor syndrome:</span></strong><span style=\"font-size:12.0pt\"> Similar to Dubin-Johnson but without liver pigmentation, causes conjugated hyperbilirubinemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gilbert syndrome presents with mild unconjugated hyperbilirubinemia, often triggered by stress, fasting, or illness, and normal liver enzyme levels.</span></span></span></p>",
      "correct_choice_id": 65714,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11216,
      "choices": [
        {
          "id": 44830,
          "text": "<p><span style=\"font-size:12.0pt;\">Brugada syndrome</span></p>"
        },
        {
          "id": 44831,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular fibrillation</span></p>"
        },
        {
          "id": 44832,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute coronary syndrome with low EF</span></p>"
        },
        {
          "id": 44833,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Automatic implantable cardioverter-defibrillator (AICD) implantation is done for which of the following conditions? (NEET PG 2018)</span></p>",
      "unique_key": "Q8392836",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012789,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. All of the above</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An Automatic Implantable Cardioverter-Defibrillator (AICD) is used for the prevention of sudden cardiac death in patients with various cardiac conditions that predispose them to life-threatening arrhythmias. The indications include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Brugada syndrome:&nbsp;</strong>A genetic disorder that can lead to dangerous ventricular arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ventricular fibrillation (VF):&nbsp;</strong>A life-threatening heart rhythm that results in rapid, inadequate heartbeats.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Acute coronary syndrome (ACS) with low ejection fraction (EF):&nbsp;</strong>After a myocardial infarction, patients with significantly reduced EF are at higher risk for ventricular arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The device is particularly beneficial in patients with structural heart disease, prior myocardial infarction, and those who have experienced syncope due to undetermined reasons but are found to have inducible ventricular tachycardia or fibrillation during electrophysiological studies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Class I Indications for AICD implantation:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">LV dysfunction with ejection fraction less than or equal to 35% and NYHA II/III symptoms.</span></li><li><span style=\"font-size:12.0pt;\">LV dysfunction with ejection fraction less than or equal to 35% due to previous Myocardial Infarction (MI) or at least 40 days post-MI and NYHA II/III symptoms.</span></li><li><span style=\"font-size:12.0pt;\">LV dysfunction with ejection fraction less than or equal to 30% due to previous Myocardial Infarction (MI) or at least 40 days post-MI.</span></li><li><span style=\"font-size:12.0pt;\">LV dysfunction with ejection fraction less than or equal to 40% due to previous Myocardial Infarction (MI) or at least 40 days post-MI and inducible VT/VF on EP study (EPS).</span></li><li><span style=\"font-size:12.0pt;\">Syncope of unknown etiology and inducible VT/ VF on EPS.</span></li><li><span style=\"font-size:12.0pt;\">Sustained VT in the presence of structural heart disease.</span></li><li><span style=\"font-size:12.0pt;\">Brugada syndrome.</span></li><li><span style=\"font-size:12.0pt;\">HCM with &gt; 1 risk factor for SCD.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21/Ventricular Arrhythmias/Chapter 252</strong></span></p>",
      "correct_choice_id": 44833,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54263,
      "choices": [
        {
          "id": 216521,
          "text": "<p><span style=\"font-size:12.0pt;\">Enoxaparin</span></p>"
        },
        {
          "id": 216522,
          "text": "<p><span style=\"font-size:12.0pt;\">Lepirudin</span></p>"
        },
        {
          "id": 216523,
          "text": "<p><span style=\"font-size:12.0pt;\">Fondaparinux</span></p>"
        },
        {
          "id": 216524,
          "text": "<p><span style=\"font-size:12.0pt;\">Dabigatran</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anticoagulants requires coagulation profile monitoring?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3370230",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012778,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Lepirudin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lepirudin is a parenteral direct thrombin inhibitor, which requires routine coagulation profile monitoring. The standard test used for monitoring Lepirudin is the activated partial thromboplastin time (aPTT). In cath labs, when administering in high doses need to be monitor with ACT (Activated Clotting Time) rather than aPTT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is necessary to ensure the correct therapeutic range is maintained and to avoid complications such as bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note - There are four parenteral direct thrombin inhibitors: lepirudin, hirudin, bivalirudin, and argatroban.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Enoxaparin</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Enoxaparin is a low molecular weight heparin (LMWH). It has a predictable anticoagulant effect, and routine coagulation monitoring is generally not required under standard clinical circumstances. In special situations, monitoring can be done using anti-factor Xa levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Fondaparinux</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Fondaparinux, like Enoxaparin, does not typically require routine coagulation monitoring due to its predictable pharmacokinetics and pharmacodynamics. In specific clinical scenarios, anti-factor Xa levels may be measured.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Dabigatran</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Dabigatran is an oral direct thrombin inhibitor and is classified under direct oral anticoagulants (DOACs). Routine coagulation monitoring is not required due to its reliable and predictable effects. However, if monitoring is needed, aPTT can be used, though more specific tests like the dilute thrombin time (dTT) or the ecarin clotting time (ECT) are preferred for accurate measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note </strong>- There are four DOACs (Direct Oral Anticoagulants): Dabigatran (direct thrombin inhibitor), Apixaban, Rivaroxaban and Edoxaban (all 3 are factor Xa inhibitor)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lepirudin, a parenteral direct thrombin inhibitor, requires routine coagulation profile monitoring using aPTT to ensure therapeutic efficacy and safety.</span></p>",
      "correct_choice_id": 216522,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11323,
      "choices": [
        {
          "id": 45258,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Superficial peroneal nerve</span></span></p>"
        },
        {
          "id": 45259,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sural nerve</span></span></p>"
        },
        {
          "id": 45260,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Saphenous nerve</span></span></p>"
        },
        {
          "id": 45261,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tibial nerve</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 54-year-old male recently underwent Coronary Artery Bypass Grafting (CABG). Within a few days after taking a saphenous vein graft, he complained of pain in the legs, and on examination, he had mild sensory loss in the medial aspect of the leg and foot on the side from where the graft was harvested. What is the nerve likely to be injured?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q4836821",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012869,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Saphenous nerve</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The saphenous nerve is a branch of the femoral nerve that provides sensory innervation to the medial aspect of the leg and foot. During coronary artery bypass grafting (CABG), the saphenous vein is often harvested for use as a graft. Due to its close anatomical relationship with the saphenous nerve, the nerve can be inadvertently injured during the vein harvesting process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Injury to the saphenous nerve typically results in sensory disturbances such as pain, numbness, or tingling in the medial aspect of the leg and foot, which matches the patient&#39;s presentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Superficial peroneal nerve:</span></strong><span style=\"font-size:12.0pt\"> The superficial peroneal nerve provides sensory innervation to the lateral aspect of the lower leg and dorsum of the foot. Injury to this nerve would cause sensory loss in these areas, not the medial aspect of the leg and foot.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Sural nerve:</span></strong><span style=\"font-size:12.0pt\"> The sural nerve supplies the lateral aspect of the foot and the posterior lower leg. Injury to the sural nerve would not affect the medial aspect of the leg and foot.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tibial nerve:</span></strong><span style=\"font-size:12.0pt\"> The tibial nerve provides motor and sensory innervation to the posterior compartment of the leg and the sole of the foot. Injury to the tibial nerve would affect these areas rather than the medial aspect of the leg and foot.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The saphenous nerve, due to its proximity to the saphenous vein, is at risk of injury during saphenous vein harvesting for CABG, leading to sensory loss in the medial aspect of the leg and foot.</span></span></span></p>",
      "correct_choice_id": 45260,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56215,
      "choices": [
        {
          "id": 224277,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retrolentiform</span></span></p>"
        },
        {
          "id": 224278,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sublentiform</span></span></p>"
        },
        {
          "id": 224279,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anterior limb</span></span></p>"
        },
        {
          "id": 224280,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Posterior limb</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male patient presented with left-sided hemiparesis. Damage to which part of the internal capsule leads to this presentation?</span></span><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2022)</span></span></p>",
      "unique_key": "Q1586147",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012859,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Posterior limb</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The internal capsule is a white matter structure in the brain that contains many important tracts, including those for motor and sensory functions. Damage to specific parts of the internal capsule can result in different clinical presentations based on the fibers that are affected.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Posterior limb</span></strong><span style=\"font-size:12.0pt\"> is the part of the internal capsule that carries corticospinal and corticobulbar tracts, which are responsible for motor and sensory functions. Damage to the posterior limb can result in contralateral hemiparesis (weakness on the opposite side of the body). Therefore, a lesion in the posterior limb of the right internal capsule would lead to left-sided hemiparesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Retrolentiform</span></strong><span style=\"font-size:12.0pt\">: This part of the internal capsule contains optic radiations, which are involved in visual processing. Damage here would lead to <strong>visual deficits</strong> rather than motor or sensory deficits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Sublentiform</span></strong><span style=\"font-size:12.0pt\">: This part carries auditory radiations and is involved in hearing. Damage to this part would result in <strong>auditory deficits,</strong> not motor weakness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Anterior limb</span></strong><span style=\"font-size:12.0pt\">: This part of the internal capsule contains frontopontine fibers and thalamocortical radiations, which are involved in <strong>cognitive and executive functions</strong>. Damage here might affect cognition but not typically result in hemiparesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Damage to the posterior limb of the internal capsule can lead to contralateral hemiparesis due to the involvement of motor and sensory pathways.</span></span></span></p>",
      "correct_choice_id": 224280,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92148,
      "choices": [
        {
          "id": 366908,
          "text": "<p><span style=\"font-size:14px;\">Air trapping with hyperinflation of lungs</span></p>"
        },
        {
          "id": 366909,
          "text": "<p><span style=\"font-size:14px;\">Decreased lung compliance</span></p>"
        },
        {
          "id": 366910,
          "text": "<p><span style=\"font-size:14px;\">Restrictive lung disease</span></p>"
        },
        {
          "id": 366911,
          "text": "<p><span style=\"font-size:14px;\">Increased lung compliance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14px;\">A 45-year-old chronic smoker presents with complaints of dyspnea. PFT reveals an FEV1/FVC ratio of 65% and an RV/TLC ratio of 141%. Which of the following best describes the underlying pathophysiology? (INICET MAY 2025)</span></p>",
      "unique_key": "Q4301786",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012776,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:14px;\"><strong>Ans. A) Air trapping with hyperinflation of lungs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14px;\">The PFT findings are characteristic of obstructive lung disease with air trapping and hyperinflation. An FEV1/FVC ratio of 65% (less than 70%) indicates small airway obstruction consistent with COPD in this chronic smoker. The RV/TLC ratio of 141% (significantly above 120%) indicates significant air trapping with hyperinflation of the lungs. When residual volume increases, it represents air trapping, and when total lung capacity increases, it represents hyperinflation. The RV/TLC ratio tells us the significance of air trapping - the more air that gets trapped, the more the FEV1 starts reducing because trapped air compromises forced expiratory capacity. This can lead to pseudo-restriction in patients with severe obstructive lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qPZ1vNT.png\" width=\"681\" height=\"567\"></span><br><br><span style=\"font-size:14px;\">&nbsp;</span></p><p><span style=\"font-size:14px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14px;\"><strong>Option B. Decreased lung compliance:</strong> This would be seen in restrictive lung disease, not in obstructive lung disease. In obstructive disease, compliance is typically normal or increased due to loss of elastic recoil.</span></p><p>&nbsp;</p><p><span style=\"font-size:14px;\"><strong>Option C. Restrictive lung disease:</strong> This would show normal or increased FEV1/FVC ratio with decreased lung volumes (TLC, RV). The reduced FEV1/FVC ratio and increased lung volumes rule out restrictive disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14px;\"><strong>Option D. Increased lung compliance:</strong> While this may be present in emphysema due to loss of elastic recoil, it is not the primary pathophysiological description for these specific PFT findings. The main issue here is air trapping and hyperinflation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14px;\">FEV1/FVC &lt;70% with RV/TLC &gt;120% indicates obstructive lung disease with air trapping and hyperinflation, typically seen in COPD.</span></p>",
      "correct_choice_id": 366908,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92148/INI_CET_May_2025_Medicine_Q_-_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92148/INI_CET_May_2025_Medicine_Q_-_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16440,
      "choices": [
        {
          "id": 65720,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myasthenia gravis</span></span></p>"
        },
        {
          "id": 65721,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Huntington chorea</span></span></p>"
        },
        {
          "id": 65722,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amyotrophic lateral sclerosis</span></span></p>"
        },
        {
          "id": 65723,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">External ophthalmoplegia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young male patient presents with ptosis which reportedly worsens in the evening and improves in the morning. He also complains of excessive fatigability towards the end of the day which improves with rest. Placing an ice pack over his eyes significantly decreases the ptosis. What is the likely diagnosis? (FMGE JUNE 2022)</span></span></span></p>",
      "unique_key": "Q2557314",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012796,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Myasthenia gravis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myasthenia gravis is characterized by fluctuating muscle weakness, worsening with activity and improving with rest. The ptosis (drooping of eyelids) improving with rest and with the application of an ice pack (ice pack test) is a classical presentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Huntington chorea:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Presents with <strong>classic triad</strong> of dementia, chorea, and psychiatric symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Amyotrophic lateral sclerosis:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Presents with both <strong>upper and lower motor neuron signs</strong>, such as spasticity and muscle wasting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. External ophthalmoplegia:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Typically involves paralysis of the eye muscles, but ptosis with diurnal variation is more indicative of myasthenia gravis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myasthenia gravis is diagnosed with fluctuating muscle weakness, ptosis, and positive ice pack test.</span></span></span></p>",
      "correct_choice_id": 65720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11257,
      "choices": [
        {
          "id": 44994,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burns</span></span></p>"
        },
        {
          "id": 44995,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stress</span></span></p>"
        },
        {
          "id": 44996,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Head injury</span></span></p>"
        },
        {
          "id": 44997,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cell necrosis</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s ulcers are seen in? (NEET PG 2019)</span></span></p>",
      "unique_key": "Q5869473",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012790,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Head injury</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s ulcers are specifically associated with head injuries or conditions that lead to increased intracranial pressure (ICP). The mechanism involves vagal nerve stimulation due to the increased ICP, which in turn causes an overproduction of gastric acid leading to the development of ulcers. This is distinct from other types of stress-related gastric ulcers.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Burns:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This type of ulcer is known as Curling&#39;s ulcer, which occurs in response to severe burns and is related to the physiological stress and possible hypovolemia resulting from the burn injury, not the brain injury-related mechanism of Cushing&#39;s ulcers.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Stress:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While stress can indeed lead to gastric ulcers, the specific term &quot;Cushing&#39;s ulcers&quot; is not used in this context. General stress-related ulcers do not typically involve the mechanism of vagal stimulation due to increased ICP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cell necrosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a general process that can occur in many pathological conditions but does not specifically relate to the formation of Cushing&#39;s ulcers.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s ulcers are a specific type of peptic ulcer that occurs due to increased intracranial pressure resulting from head injuries. Recognizing this condition is important for managing patients with significant neurological trauma to prevent and treat these potentially serious gastrointestinal complications.</span></span></p>",
      "correct_choice_id": 44996,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11527,
      "choices": [
        {
          "id": 46074,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 46075,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 46076,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 46077,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a PHC, which of the following initial screening tests are used to diagnose diabetes? (INICET MAY 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">HbA1c &gt;6.5</span></li><li><span style=\"font-size:12.0pt;\">Fasting blood sugar &gt;126 mg/dL</span></li><li><span style=\"font-size:12.0pt;\">Random blood sugar &gt;200 mg/dL</span></li><li><span style=\"font-size:12.0pt;\">2-hour post glucose load blood sugar</span></li></ol>",
      "unique_key": "Q5563170",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012784,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The initial screening tests for diagnosing diabetes in a primary health care setting generally include the following criteria:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Fasting blood sugar &gt;126 mg/dL:</strong> A fasting blood glucose level of 126 mg/dL or higher on two separate occasions indicates diabetes. Fasting is defined as no caloric intake for at least 8 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Random blood sugar &gt;200 mg/dL:</strong> A random blood glucose level of 200 mg/dL or higher, along with symptoms of diabetes, is sufficient for diagnosis. This test does not require fasting and can be taken at any time.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. HbA1c &gt;6.5%:</strong> While this test is beneficial for its ability to reflect average blood glucose levels over the past two to three months and does not require fasting, its higher cost and need for more sophisticated laboratory equipment make it less likely to be used at PHCs in India.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. 2-hour post glucose load blood sugar:</strong> Part of the Oral Glucose Tolerance Test (OGTT), this test is more comprehensive but requires more time and resources, which may not be feasible in all primary care settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The initial screening tests for diagnosing diabetes in a primary health care (PHC) setting typically include fasting blood sugar &gt;126 mg/dL, and random blood sugar &gt;200 mg/dL. These tests are widely accepted and feasible in most PHC settings.</span></p>",
      "correct_choice_id": 46075,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57158,
      "choices": [
        {
          "id": 228021,
          "text": "<p><span style=\"font-size:11.0pt;\">HDL levels</span></p>"
        },
        {
          "id": 228022,
          "text": "<p><span style=\"font-size:11.0pt;\">Hip circumference</span></p>"
        },
        {
          "id": 228023,
          "text": "<p><span style=\"font-size:11.0pt;\">Blood glucose</span></p>"
        },
        {
          "id": 228024,
          "text": "<p><span style=\"font-size:11.0pt;\">Blood pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following will not be measured to diagnose metabolic syndrome? (INICET MAY 2023)</span></p>",
      "unique_key": "Q7834727",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012857,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B)&nbsp;Hip circumference</strong></span></p><p><br><span style=\"font-size:12pt;\">Metabolic syndrome criteria include: HDL levels, Blood glucose, Blood pressure and Waist circumference (NOT hip circumference)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Waist circumference</strong> - more than 102 centimeter in males or more than 88 centimeter in females&nbsp;is one of the important criteria for metabolic syndrome. Central obesity is a criterion for metabolic syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option A. HDL levels</strong>: Low HDL levels (&lt;40 mg/dL in males, &lt;50 mg/dL in females) are a criterion for metabolic syndrome.</span></p><p><span style=\"font-size:12.0pt;\">High triglyceride levels (&gt;150 mg/dL) are a criterion for metabolic syndrome.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option C. Blood glucose</strong>: Impaired glucose tolerance or type 2 diabetes is a criterion for metabolic syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Blood pressure:</strong> BP &gt;140/90 mmHg or being hypertensive is a criterion for metabolic syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Note - </strong>To diagnose metabolic syndrome, the presence of at least three of these criteria is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hip circumference is not used in the diagnosis of metabolic syndrome; instead, waist circumference is measured.</span></p>",
      "correct_choice_id": 228022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11751,
      "choices": [
        {
          "id": 46970,
          "text": "<p><span style=\"font-size:12.0pt;\">LDH</span></p>"
        },
        {
          "id": 46971,
          "text": "<p><span style=\"font-size:12.0pt;\">Troponin-T</span></p>"
        },
        {
          "id": 46972,
          "text": "<p><span style=\"font-size:12.0pt;\">CKMB</span></p>"
        },
        {
          "id": 46973,
          "text": "<p><span style=\"font-size:12.0pt;\">BNP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with the complaints of chest pain. Which among the following is the best investigation to diagnose MI within 2-4 hours? (INICET NOV 2020)</span></p>",
      "unique_key": "Q7231088",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012785,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Troponin – T</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Troponin-T is the most sensitive and specific biomarker available for diagnosing myocardial infarction (MI) within the early hours of symptom onset. It begins to rise within 3-4 hours of myocardial damage, peaks at around 12-48 hours, and remains elevated for up to 7-10 days, making it highly useful for early diagnosis and detection of recent heart damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. LDH:</strong>&nbsp;it is a less specific enzyme that may be elevated in many types of tissue damage and is not ideal for early diagnosis of MI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CKMB: it&nbsp;</strong>rises within 4-8 hours of myocardial injury, making it less useful than Troponin-T in the very early stages post-symptom onset.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. BNP:&nbsp;</strong>it is primarily used to assess heart failure and is not a primary marker for acute myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-110113.png\" alt=\"\" width=\"1000\" height=\"414\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rise by &gt;20%of troponin is used for diagnosis of Reinfarction</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Newer biomarkers: HFABP, miRNA1,21,33</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - (Cardiology/Biomarkers, MI)</strong></span></p>",
      "correct_choice_id": 46971,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48852,
      "choices": [
        {
          "id": 194987,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in FEV1/FVC</span></p>"
        },
        {
          "id": 194988,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt;200 ml increase in FEV1 after methacholine</span></p>"
        },
        {
          "id": 194989,
          "text": "<p><span style=\"font-size:12.0pt;\">Diurnal variation in PEF &gt;20%</span></p>"
        },
        {
          "id": 194990,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduction of FEV1 &gt;20% after bronchodilators</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a patient with clinical signs of asthma, which of the following tests will confirm the diagnosis? (NEET PG 2017)</span></p>",
      "unique_key": "Q6808949",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012865,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. C) Diurnal variation in PEF &gt;20%</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Asthma is characterized by variable airflow obstruction, and one of the key diagnostic criteria is demonstrating this variability. Asthma diagnosis is based on reversible obstruction along with the classic triad of bronchodilator responsiveness, variability, and airway hyperresponsiveness. Diurnal variations in peak expiratory flow (PEF) &gt;20% confirms the variable nature of airflow obstruction that is characteristic of asthma.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Increase in FEV1/FVC</strong>:&nbsp; Asthma typically causes a decrease in FEV1/FVC ratio due to airflow obstruction. In asthma, airflow limitation is the major physiologic change and would cause a reduced FEV1/FVC, not an increase.<br><br>&nbsp;</p><p><strong>Option B. &gt;200 ml increase in FEV1 after methacholine</strong>: Methacholine is a bronchoconstrictor used in challenge testing to demonstrate airway hyperresponsiveness. It causes a decrease in FEV1, not an increase. Methacholine challenge is used when the diagnosis of asthma is in doubt.<br><br>&nbsp;</p><p><strong>Option D. Reduction of FEV1 &gt;20% after bronchodilators</strong>: Bronchodilators should improve airflow in asthma, not worsen it. Bronchodilator response in asthma is characterized by an increase in FEV1 (&gt;12% and 200-mL) after administration of a short-acting β2-agonist.<br><br>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diurnal variation in PEF &gt;20% is a key diagnostic feature of asthma, reflecting the variable airway obstruction that characterizes the disease.</span></p>",
      "correct_choice_id": 194989,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11755,
      "choices": [
        {
          "id": 46986,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal disorders</span></span></span></span></p>"
        },
        {
          "id": 46987,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactic acidosis</span></span></span></span></p>"
        },
        {
          "id": 46988,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetic ketoacidosis</span></span></span></span></p>"
        },
        {
          "id": 46989,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salicylate poisoning</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap acidosis with low bicarbonate levels is seen in all the following conditions except: (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q5808368",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012862,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal Disorders</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap metabolic acidosis (HAGMA) is characterized by the accumulation of acids in the body, which are not accompanied by an increase in other measured anions, thus increasing the anion gap. This condition typically involves a decrease in bicarbonate as the body tries to buffer the excess hydrogen ions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Lactic Acidosis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This condition occurs when lactate levels increase in the bloodstream during tissue hypoxia, commonly seen in shock or severe dehydration, and results in HAGMA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Diabetic Ketoacidosis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In DKA, the body produces high levels of blood acids called ketones, which lead to HAGMA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Salicylate Poisoning</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In salicylate toxicity, especially at higher doses, metabolic acidosis occurs due to uncoupling of oxidative phosphorylation, leading to HAGMA. Initially, salicylate stimulates the respiratory center causing a respiratory alkalosis, which can be followed by metabolic acidosis at higher doses.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal disorders typically cause non-anion gap metabolic acidosis (NAGMA) due to an inability to excrete acid or conserve bicarbonate, rather than high anion gap acidosis seen in conditions like lactic acidosis, diabetic ketoacidosis, and salicylate poisoning.</span></span></span></span></p>",
      "correct_choice_id": 46986,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11833,
      "choices": [
        {
          "id": 47298,
          "text": "<p><span style=\"font-size:12.0pt;\">1-5% of the population can have epileptiform discharges.</span></p>"
        },
        {
          "id": 47299,
          "text": "<p><span style=\"font-size:12.0pt;\">Scalp EEG may be helpful in localizing frontal lobe epilepsy.</span></p>"
        },
        {
          "id": 47300,
          "text": "<p><span style=\"font-size:12.0pt;\">Doing EEG is mandatory for the diagnosis of seizures.</span></p>"
        },
        {
          "id": 47301,
          "text": "<p><span style=\"font-size:12.0pt;\">Progressive multifocal leukoencephalopathy shows triphasic and slow waves.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">True about electroencephalogram (EEG) is all except: (INICET NOV 2021)</span></p>",
      "unique_key": "Q8403798",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012783,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Doing EEG is mandatory for the diagnosis of seizures.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Electroencephalography (EEG) is a key diagnostic tool in the evaluation of neurological conditions, particularly epilepsy. However, it is not mandatory for the diagnosis of seizures. A patient can have seizures even if their EEG results are normal. <strong>An abnormal EEG can provide reassurance of a diagnosis of epilepsy when the clinical context supports it, but a normal EEG does not rule out epilepsy or seizures.</strong> Therefore, making an EEG mandatory for the diagnosis of seizures is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>1-5% of the population can have epileptiform discharges: </strong>This statement is correct. Epileptiform discharges can be present in a small percentage of the general population without necessarily indicating that the individual has epilepsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Scalp EEG may be helpful in localizing frontal lobe epilepsy: </strong>This statement is correct. Scalp EEG can indeed help localize the origin of epileptic activity, including frontal lobe epilepsy, although it might not always be definitive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Progressive multifocal leukoencephalopathy shows triphasic and slow waves: </strong>This statement is correct. Progressive multifocal leukoencephalopathy (PML) and other forms of encephalopathy can show triphasic waves and slow wave patterns on an EEG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">EEG is not mandatory for the diagnosis of seizures as patients can have seizures even with a normal EEG.</span></p>",
      "correct_choice_id": 47300,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24780,
      "choices": [
        {
          "id": 99081,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4</span></p>"
        },
        {
          "id": 99082,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2</span></p>"
        },
        {
          "id": 99083,
          "text": "<p><span style=\"font-size:12.0pt;\">3,4</span></p>"
        },
        {
          "id": 99084,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3,4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female with nephrotic syndrome underwent a renal biopsy. Which of the following statements is correct? (INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">FSGS cannot be diagnosed by a percutaneous renal biopsy</span></li><li><span style=\"font-size:12.0pt;\">Patient should be observed for 24 hours following biopsy</span></li><li><span style=\"font-size:12.0pt;\">Dark red clots in the urine following a biopsy indicate a hematoma</span></li><li><span style=\"font-size:12.0pt;\">Patients with features of systemic amyloidosis and renal involvement can undergo abdominal fat pad biopsy instead of renal biopsy</span></li></ol>",
      "unique_key": "Q1461879",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012780,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 2,3,4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Following a renal biopsy, it is crucial to monitor the patient for potential complications, including bleeding and hematoma formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Observation post-biopsy:</strong> Patients should be observed for 24 hours following a renal biopsy to monitor for complications such as bleeding or infection.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Dark red clots in urine: </strong>Dark red clots in the urine following a biopsy can indicate a hematoma. This is a potential complication that needs to be monitored.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Abdominal fat pad biopsy:</strong> Patients with systemic amyloidosis and renal involvement can undergo an abdominal fat pad biopsy as an alternative to a renal biopsy. This method can help diagnose systemic amyloidosis with less risk compared to a renal biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. FSGS cannot be diagnosed by a percutaneous renal biopsy</strong>: This statement is incorrect. Focal segmental glomerulosclerosis (FSGS) can indeed be diagnosed by a percutaneous renal biopsy. The biopsy helps in identifying the characteristic histological changes associated with FSGS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Post-biopsy observation, recognition of biopsy-related complications, and alternative biopsy methods for systemic amyloidosis are essential in nephrotic syndrome management.</span></p>",
      "correct_choice_id": 99084,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54289,
      "choices": [
        {
          "id": 216625,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non-Anion Gap Metabolic Acidosis (NAGMA)</span></span></span></p>"
        },
        {
          "id": 216626,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High Anion Gap Metabolic Acidosis (HAGMA)</span></span></span></p>"
        },
        {
          "id": 216627,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Compensated Metabolic Alkalosis</span></span></span></p>"
        },
        {
          "id": 216628,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Respiratory Acidosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient arrives at the emergency department presenting with symptoms of abdominal pain, vomiting, tachypnea, and tachycardia. Laboratory results are as follows: pH: 7.34, Sodium: 135 mmol/L, Potassium: 5 mmol/L, Bicarbonate: 12 mmol/L, Chloride: 92 mmol/L, RBS: 450 mg/dL. Given these laboratory findings, which of the following statements best describes the patient&#39;s acid-base status?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3295743",
      "question_audio": null,
      "question_video": null,
      "map_id": 35123510,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B) High Anion Gap Metabolic Acidosis (HAGMA)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient&#39;s clinical presentation and laboratory findings suggest diabetic ketoacidosis (DKA), a condition commonly seen in diabetes patients with high blood sugar levels (RBS: 450 mg/dL). The symptoms of abdominal pain, vomiting, tachypnea (rapid breathing), and tachycardia (rapid heart rate) are characteristic of DKA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The laboratory values indicate a metabolic acidosis:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">pH of 7.34</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Slightly acidic, indicating acidosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bicarbonate of 12 mmol/L</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Low, consistent with metabolic acidosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chloride of 92 mmol/L</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Lower than normal.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To determine the type of metabolic acidosis, we calculate the anion gap: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-125329.jpg\" style=\"height:66px; width:900px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An anion gap greater than 12 mmol/L indicates a high anion gap metabolic acidosis (HAGMA). In this case, the anion gap is 31, confirming HAGMA.&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High anion gap metabolic acidosis is typically associated with conditions such as diabetic ketoacidosis, lactic acidosis, renal failure, and ingestion of toxins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Non-Anion Gap Metabolic Acidosis (NAGMA)</strong>: This occurs when the anion gap is normal (less than 12 mmol/L). Conditions that cause NAGMA include diarrhea and renal tubular acidosis. This does not match the patient&#39;s high anion gap.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Compensated Metabolic Alkalosis</strong>: This condition involves an elevated pH with high bicarbonate levels. The patient&rsquo;s pH is acidic, not alkalotic, and bicarbonate is low.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Respiratory Acidosis</strong>: Characterized by a primary increase in carbon dioxide (CO2) levels leading to a low pH. The patient&rsquo;s primary disturbance is metabolic, not respiratory.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap metabolic acidosis (HAGMA) is characterized by an anion gap greater than 12 mmol/L, indicating an accumulation of unmeasured anions. This condition is often seen in diabetic ketoacidosis, which presents with elevated blood glucose levels and metabolic acidosis.</span></span></p>",
      "correct_choice_id": 216626,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54264,
      "choices": [
        {
          "id": 216525,
          "text": "<p><span style=\"font-size:12.0pt;\">Ehlers-Danlos Syndrome</span></p>"
        },
        {
          "id": 216526,
          "text": "<p><span style=\"font-size:12.0pt;\">Marfan's Syndrome</span></p>"
        },
        {
          "id": 216527,
          "text": "<p><span style=\"font-size:12.0pt;\">Atherosclerosis</span></p>"
        },
        {
          "id": 216528,
          "text": "<p><span style=\"font-size:12.0pt;\">Scurvy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following connective tissue degradation disorder is associated with aortic aneurysm?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1616423",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012855,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Marfan's Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Marfan's Syndrome is a connective tissue disorder that affects the body's connective tissues, which provide structural support to various organs and tissues. It is particularly associated with cardiovascular complications, including aortic aneurysms and dissections. This is due to the weakening of the aortic wall caused by defective fibrillin-1, a glycoprotein essential for the elasticity and strength of the connective tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Ehlers-Danlos Syndrome</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">While Ehlers-Danlos Syndrome (EDS) can lead to vascular complications, including aortic aneurysms, it is specifically the vascular type (Type IV) of EDS that is associated with these issues. However, Marfan's Syndrome is more commonly linked to aortic aneurysms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Atherosclerosis</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Atherosclerosis is a condition characterized by the build-up of plaque within the arterial walls, leading to narrowing and hardening of the arteries. It is a risk factor for abdominal aortic aneurysm but is not classified as a connective tissue disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Scurvy</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Scurvy is caused by a deficiency in vitamin C, leading to defective collagen synthesis. While it results in symptoms like mucosal bleeding and poor wound healing, it is not associated with aortic aneurysms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Marfan's Syndrome is a connective tissue disorder closely associated with the development of aortic aneurysms due to the defective fibrillin-1 protein affecting the structural integrity of the aortic wall.</span></p>",
      "correct_choice_id": 216526,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84276,
      "choices": [
        {
          "id": 335684,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 335685,
          "text": "<p><span style=\"font-size:12.0pt;\">Morphine</span></p>"
        },
        {
          "id": 335686,
          "text": "<p><span style=\"font-size:12.0pt;\">Furosemide</span></p>"
        },
        {
          "id": 335687,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-invasive Positive Pressure Ventilation</span></p>"
        }
      ],
      "text": "<p>Which of the following is not typically used in the initial treatment of acute, life-threatening cardiogenic pulmonary edema? (NEET PG 2016)</p>",
      "unique_key": "Q9067136",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012787,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. A) Digoxin</strong></p><p>&nbsp;</p><p>Digoxin is <strong>not</strong> part of the initial treatment for acute, life-threatening cardiogenic pulmonary edema. The initial management of acute heart failure with pulmonary edema follows the mnemonic \"LMNOP\" - Loop diuretics, Morphine, Nitrates, Oxygen, and Position (fowler's position). Digoxin has no role in the acute management of cardiogenic pulmonary edema and is generally relegated to therapy for patients with chronic heart failure who remain profoundly symptomatic despite optimal neurohormonal blockade.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Morphine</strong>:&nbsp; Morphine is included in the \"LMNOP\" mnemonic (the \"M\") for treating acute heart failure with pulmonary congestion. It helps reduce anxiety, preload, and afterload in the setting of acute pulmonary edema.</p><p>&nbsp;</p><p><strong>Option C. Furosemide</strong>: Loop diuretics like furosemide are the \"L\" in the \"LMNOP\" mnemonic and are essential first-line agents to address congestion in acute heart failure with pulmonary edema. They promote rapid diuresis and venodilation.</p><p>&nbsp;</p><p><strong>Option D. Non-invasive Positive Pressure Ventilation</strong>: This is represented by \"O\" for oxygen in the \"LMNOP\" mnemonic. Non-invasive ventilation is a key component of the initial management of acute pulmonary edema.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>The acute management of cardiogenic pulmonary edema focuses on immediate relief of congestion and respiratory distress using the \"LMNOP\" approach (Loop diuretics, Morphine, Nitrates, Oxygen/non-invasive ventilation, and Positioning), while digoxin is reserved for chronic heart failure management in specific situations.</p>",
      "correct_choice_id": 335684,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11265,
      "choices": [
        {
          "id": 45026,
          "text": "<p><span style=\"font-size:12.0pt;\">Class A</span></p>"
        },
        {
          "id": 45027,
          "text": "<p><span style=\"font-size:12.0pt;\">Class B</span></p>"
        },
        {
          "id": 45028,
          "text": "<p><span style=\"font-size:12.0pt;\">Class C</span></p>"
        },
        {
          "id": 45029,
          "text": "<p><span style=\"font-size:12.0pt;\">Class D</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the Child-Turcotte-Pugh (CTP) class for the patient who has a serum bilirubin 2.5 mg/dl, serum albumin 3 g/dL, prothrombin time 5 seconds (INR = 2), no encephalopathy, and mild ascites?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
      "unique_key": "Q4854419",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012868,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Class B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To determine the Child-Turcotte-Pugh (CTP) score, each of the five clinical measures is scored with points from 1 to 3 based on specific criteria:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Bilirubin:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">&lt;2 mg/dL = 1 point</span></li><li><span style=\"font-size:12.0pt;\">2-3 mg/dL = 2 points (Patient has 2.5 mg/dL)</span></li><li><span style=\"font-size:12.0pt;\">3 mg/dL = 3 points</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Albumin:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">3.5 g/dL = 1 point</span></li><li><span style=\"font-size:12.0pt;\">2.8-3.5 g/dL = 2 points</span></li><li><span style=\"font-size:12.0pt;\">&lt;2.8 g/dL = 3 points (Patient has 3 g/dL, scoring 2 points)</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>INR:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">1-1.7 = 1 point</span></li><li><span style=\"font-size:12.0pt;\">1.8-2.3 = 2 points (Patient has INR = 2)</span></li><li><span style=\"font-size:12.0pt;\">2.3 = 3 points</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Ascites:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">None = 1 point</span></li><li><span style=\"font-size:12.0pt;\">Controlled = 2 points (Patient has mild ascites, scoring 2 points)</span></li><li><span style=\"font-size:12.0pt;\">Refractory = 3 points</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Encephalopathy:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">None = 1 point (Patient has none)</span></li><li><span style=\"font-size:12.0pt;\">Grade 1-2 = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Grade 3-4 = 3 points</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Scoring Calculation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Bilirubin = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Albumin = 2 points</span></li><li><span style=\"font-size:12.0pt;\">INR = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Ascites = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Encephalopathy = 1 point</span><br><span style=\"font-size:12.0pt;\">Total = 9 points</span></li></ul><p><span style=\"font-size:12.0pt;\">The patient scores 9 points, placing them in Child-Turcotte-Pugh Class B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Child-Turcotte-Pugh scoring system</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-185922.jpg\" alt=\"\" width=\"1000\" height=\"462\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Inference:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>CTP A:</strong> 5-6</span></li><li><span style=\"font-size:12.0pt;\"><strong>CTP B: </strong>7-9</span></li><li><span style=\"font-size:12.0pt;\"><strong>CTP C: </strong>10-15</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cirrhosis/Chapter 344</strong></span></p>",
      "correct_choice_id": 45027,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74883,
      "choices": [
        {
          "id": 298433,
          "text": "<p><span style=\"font-size:16px;\">Diarrhea</span></p>"
        },
        {
          "id": 298434,
          "text": "<p><span style=\"font-size:16px;\">Diabetic ketoacidosis (DKA)</span></p>"
        },
        {
          "id": 298435,
          "text": "<p><span style=\"font-size:16px;\">Acute renal failure</span></p>"
        },
        {
          "id": 298436,
          "text": "<p><span style=\"font-size:16px;\">Inborn errors of metabolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">High Anion Gap Metabolic Acidosis (HAGMA) is not caused by: (INICET NOV 2024)</span></p>",
      "unique_key": "Q1263186",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012777,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Diarrhea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Diarrhea causes Normal Anion Gap Metabolic Acidosis (NAGMA), not High Anion Gap Metabolic Acidosis (HAGMA). There are only three main causes of NAGMA, remembered by the mnemonic \"DRS\":</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">D: Diarrhea</span></li><li><span style=\"font-size:16px;\">R: RTA (Renal Tubular Acidosis – types 1, 2, and 4)</span></li><li><span style=\"font-size:16px;\">S: Saline administration (causing hyperchloremic metabolic acidosis)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Diabetic ketoacidosis (DKA):</strong> Incorrect. DKA is a classic cause of HAGMA. It leads to accumulation of ketone bodies, causing high anion gap.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Acute renal failure:</strong> Incorrect. Renal failure causes HAGMA due to accumulation of organic acids and decreased acid excretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Inborn errors of metabolism:</strong> Incorrect. Most inborn errors of metabolism cause HAGMA through accumulation of organic acids.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The causes of HAGMA can be remembered using the mnemonic <strong>\"GOLDMARK\"</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">G: Glycol (ethylene glycol)</span></li><li><span style=\"font-size:16px;\">O: Oxoproline (paracetamol metabolite)</span></li><li><span style=\"font-size:16px;\">L: L-lactate</span></li><li><span style=\"font-size:16px;\">D: D-lactate (short bowel syndrome)</span></li><li><span style=\"font-size:16px;\">M: Methanol</span></li><li><span style=\"font-size:16px;\">A: Aspirin</span></li><li><span style=\"font-size:16px;\">R: Renal failure</span></li><li><span style=\"font-size:16px;\">K: Ketoacidosis (diabetic, alcoholic, starvation)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Diarrhea causes Normal Anion Gap Metabolic Acidosis (NAGMA), not High Anion Gap Metabolic Acidosis (HAGMA).</span></p>",
      "correct_choice_id": 298433,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48229,
      "choices": [
        {
          "id": 192511,
          "text": "<p>There is an incremental response on 2-3 Hz nerve stimulation</p>"
        },
        {
          "id": 192512,
          "text": "<p>Antibodies are directed against voltage-gated calcium channels (VGCC)</p>"
        },
        {
          "id": 192513,
          "text": "<p>Reflexes are absent or depressed</p>"
        },
        {
          "id": 192514,
          "text": "<p>Patients experience autonomic changes</p>"
        }
      ],
      "text": "<p>Which of the following statements about Lambert-Eaton Myasthenic Syndrome (LEMS) is NOT correct? (NEET PG 2015)</p>",
      "unique_key": "Q9680294",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012863,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer:</strong> <strong>A.</strong> <strong>There is an incremental response on 2-3 Hz nerve stimulation</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Lambert-Eaton Myasthenic Syndrome (LEMS) is a presynaptic disorder of the neuromuscular junction. In LEMS, at low rates of repetitive nerve stimulation (2-3 Hz), a decremental response is observed, similar to myasthenia gravis. However, at high rates of stimulation (20-50 Hz) or following brief exercise, an incremental response occurs, which is characteristic of LEMS. This distinguishes LEMS from myasthenia gravis. LEMS is caused by autoantibodies directed against P/Q-type calcium channels at motor nerve terminals, which impair acetylcholine release.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Antibodies are directed against voltage:</strong> gated calcium channels (VGCC) - This statement is correct. LEMS is caused by autoantibodies directed against P/Q-type calcium channels at the motor nerve terminals, detected in approximately 85% of LEMS patients. These autoantibodies impair the release of acetylcholine from nerve terminals.</p><p>&nbsp;</p><p><strong>Option C. Reflexes are absent or depressed:</strong> This statement is correct. In LEMS, patients have depressed or absent reflexes, which is a distinguishing feature from myasthenia gravis.</p><p>&nbsp;</p><p><strong>Option D. Patients experience autonomic changes:&nbsp;</strong>This statement is correct. LEMS patients experience autonomic changes such as dry mouth and impotence, which are characteristic features of the condition.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>In LEMS, a decremental response occurs at low rates of nerve stimulation (2-3 Hz), while an incremental response is seen at high rates of stimulation (20-50 Hz) or after brief exercise—this electrophysiologic pattern helps distinguish LEMS from myasthenia gravis.</p>",
      "correct_choice_id": 192511,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47541,
      "choices": [
        {
          "id": 189775,
          "text": "<p><span style=\"font-size:12.0pt;\">Wheat</span></p>"
        },
        {
          "id": 189776,
          "text": "<p><span style=\"font-size:12.0pt;\">Barley</span></p>"
        },
        {
          "id": 189777,
          "text": "<p><span style=\"font-size:12.0pt;\">Oats</span></p>"
        },
        {
          "id": 189778,
          "text": "<p><span style=\"font-size:12.0pt;\">Rice</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient with celiac disease is recommended a gluten-free diet. Which among the following can she consume?</span></p>",
      "unique_key": "Q3208875",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012798,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Rice</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Celiac disease requires a strict gluten-free diet to avoid triggering symptoms. Gluten is found in certain grains, specifically:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mnemonic - BROW</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Barley</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Rye</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Oats&nbsp;</strong>(unless specifically labeled gluten-free due to potential cross-contamination)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Wheat</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Rice&nbsp;</strong>is naturally gluten-free and safe for consumption by individuals with celiac disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Wheat:&nbsp;</strong>Contains gluten and must be avoided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Barley:&nbsp;</strong>Contains gluten and must be avoided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Oats:&nbsp;</strong>Often contaminated with gluten unless specifically labeled gluten-free and should be avoided unless confirmed to be safe.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Individuals with celiac disease should avoid wheat, barley, rye, and oats unless specifically labelled gluten-free, while rice is a safe option.</span></p>",
      "correct_choice_id": 189778,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55353,
      "choices": [
        {
          "id": 220873,
          "text": "<p><span style=\"font-size:12pt;\">Transposition of great vessels</span></p>"
        },
        {
          "id": 220874,
          "text": "<p><span style=\"font-size:12pt;\">Coarctation of Aorta</span></p>"
        },
        {
          "id": 220875,
          "text": "<p><span style=\"font-size:12pt;\">Tetralogy of Fallot</span></p>"
        },
        {
          "id": 220876,
          "text": "<p><span style=\"font-size:12pt;\">Ebstein’s anomaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient presented with strong upper limb pulses and weak lower limb pulses with chest x-ray showing rib notching. What is the diagnosis?<strong> </strong>(FMGE JULY 2024)</span></p>",
      "unique_key": "Q9172244",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012774,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Coarctation of Aorta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The classic presentation of coarctation of the aorta, a congenital condition characterized by the narrowing of the aorta. This narrowing typically occurs just after the arteries that branch off to the upper body, leading to a disparity in blood flow and pressure between the upper and lower parts of the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Key indicators in this case include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Strong upper limb pulses and weak lower limb pulses:</strong> The narrowing restricts blood flow to the lower extremities, causing the upper body to receive a higher volume of blood, which results in stronger pulses in the upper limbs compared to the lower limbs.</span></li><li><span style=\"font-size:12pt;\"><strong>Chest x-ray showing rib notching:</strong> Rib notching is a result of enlarged intercostal arteries that form collateral pathways to bypass the narrowed aorta. These arteries erode the underside of the ribs over time, creating a notched appearance on chest x-rays.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Transposition of great vessels:</strong> This condition involves the switching of the major arteries (the aorta and the pulmonary artery) from their normal positions. It does not present with rib notching or a difference in pulse strength between the upper and lower limbs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Tetralogy of Fallot:</strong> This is a combination of four heart defects, including a ventricular septal defect, pulmonary stenosis, right ventricular hypertrophy, and an overriding aorta. It primarily presents with cyanosis and does not typically involve rib notching or differential limb pulses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Ebstein’s anomaly:</strong> This is a rare heart defect affecting the tricuspid valve and right ventricle. It does not cause rib notching or a significant difference in pulse strength between upper and lower limbs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Coarctation of the aorta is identified by the presence of strong upper limb pulses, weak lower limb pulses, and rib notching on a chest x-ray, which is caused by collateral circulation developing around the narrowed section of the aorta.</span></p>",
      "correct_choice_id": 220874,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11306,
      "choices": [
        {
          "id": 45190,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Protein losing enteropathy</span></span></p>"
        },
        {
          "id": 45191,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Distal intestinal obstruction</span></span></p>"
        },
        {
          "id": 45192,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypernatremia</span></span></p>"
        },
        {
          "id": 45193,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rectal prolapse occurs after treatment</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 10-year-old child presented with recurrent pulmonary infections and bulky greasy stools. Quantitative estimation of the stool fat was more than 10g/day. Which of the following will be seen in this child?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q5672760",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012792,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Distal intestinal obstruction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The child&#39;s presentation of recurrent pulmonary infections and steatorrhea (bulky, greasy stools) is <strong>indicative of cystic fibrosis (CF).</strong> CF is a genetic disorder that affects the lungs and digestive system, leading to severe respiratory infections and malabsorption of nutrients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In CF, thick mucus secretions can lead to blockages in various parts of the body. One of the common gastrointestinal complications is distal intestinal obstruction syndrome (DIOS), where thickened stool causes obstruction in the distal part of the small intestine. This condition is seen more frequently in older children and adults with CF, especially after the introduction of pancreatic enzyme replacement therapy (PERT).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The treatment of choice for distal intestinal obstruction syndrome (DIOS), which primarily involves the use of laxatives like PEG (Polyethylene glycol) is effective because it works by osmotically drawing water into the intestine, which helps to soften the stool and promote bowel movements, thereby alleviating the obstruction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Protein losing enteropathy:</span></strong><span style=\"font-size:12.0pt\"> This condition can occur in CF, but it is more common in the infantile period or up to 2 years of age due to exocrine pancreatic insufficiency. It is not a primary concern in a 10-year-old child with CF presenting with the given symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hypernatremia:</span></strong><span style=\"font-size:12.0pt\"> Hypernatremia is not typically seen in CF. Instead, CF patients often exhibit hyponatremia, hypochloremia, and metabolic alkalosis due to excessive chloride loss through sweat. This electrolyte imbalance is characteristic of CF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Rectal prolapse occurs after treatment:</span></strong><span style=\"font-size:12.0pt\"> Rectal prolapse was historically a common manifestation of untreated CF in young children. However, with effective treatment, including pancreatic enzyme replacement therapy, rectal prolapse is now rare and does not usually occur after treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In children with cystic fibrosis, recurrent pulmonary infections and steatorrhea are common, and one of the significant gastrointestinal complications is distal intestinal obstruction syndrome (DIOS). This condition should be considered in CF patients presenting with symptoms of intestinal obstruction.</span></span></p>",
      "correct_choice_id": 45191,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16178,
      "choices": [
        {
          "id": 64672,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute respiratory distress syndrome</span></span></span></p>"
        },
        {
          "id": 64673,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cardiac arrhythmia</span></span></span></p>"
        },
        {
          "id": 64674,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cerebral edema</span></span></span></p>"
        },
        {
          "id": 64675,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute kidney injury</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is the most common cause of mortality in DKA?</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (FMGE JAN 2023)</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></p>",
      "unique_key": "Q1944650",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012771,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>C) Cerebral edema</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cerebral edema is the most common cause of mortality in diabetic ketoacidosis (DKA), particularly in children. During the treatment of DKA, rapid shifts in serum osmolality occur when blood glucose levels are lowered too quickly with insulin therapy. Initially, the patient&#39;s serum osmolality is high due to hyperglycemia. Rapid correction of blood glucose levels can lead to a decrease in serum osmolality, while the intracellular fluid (ICF) osmolality remains high. This osmotic imbalance causes water to move from the extracellular fluid (ECF) into the intracellular space, resulting <strong>in cerebral edema&nbsp;</strong></span><strong><span style=\"font-size:12.0pt\">(MC cause of death)</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Second MCC of death is Cardiac arrythmias due to potassium disturbance &ndash; </span><span style=\"font-size:12.0pt\">Hyperkalemia at presentation and Hypokalemia after Starting Insulin Therapy, due to the shift of potassium into cells as blood glucose levels are reduced, </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">which affect cardiac function</span><span style=\"font-size:12.0pt\">.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Acute respiratory distress syndrome:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While it is a serious condition, it is not a common cause of mortality in DKA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Cardiac arrhythmia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Although cardiac arrhythmias due to potassium disturbances (hyperkalemia at presentation and hypokalemia during treatment) are significant, they are not the most common cause of death in DKA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Acute kidney injury:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This can occur in DKA but is not the primary cause of mortality.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cerebral edema is the most common cause of mortality in diabetic ketoacidosis, especially during the treatment phase when rapid shifts in osmolality occur.</span></span></span></p>",
      "correct_choice_id": 64674,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11888,
      "choices": [
        {
          "id": 47517,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Piperacillin-Tazobactam</span></span></p>"
        },
        {
          "id": 47518,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amoxicillin-Clavulanate</span></span></p>"
        },
        {
          "id": 47519,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ceftriaxone</span></span></p>"
        },
        {
          "id": 47520,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nitrofurantoin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with diabetes develops a UTI, which gets complicated with hypotension that is resistant to IV fluids. Which of the following antibiotics can be used? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q9133877",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012781,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Piperacillin-Tazobactam</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient with diabetes has developed a urinary tract infection (UTI) complicated by hypotension resistant to IV fluids, indicating septic shock. In cases of septic shock, it is critical to start with empirical broad-spectrum antibiotics. These antibiotics are designed to cover a wide range of potential pathogens until the specific causative organism can be identified and targeted.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Broad-spectrum antibiotics suitable for such severe infections include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Piperacillin-Tazobactam</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carbapenems like Meropenem or Imipenem</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Certain third-generation cephalosporins like Ceftazidime</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case, Piperacillin-Tazobactam is chosen because it is a broad-spectrum antibiotic that covers many of the common pathogens responsible for severe infections and septic shock. Although a combination of Meropenem with Vancomycin would be ideal, the given options do not include Meropenem. Therefore, Piperacillin-Tazobactam is the best choice among the provided options.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Amoxicillin-Clavulanate:</span></strong><span style=\"font-size:12.0pt\"> This antibiotic is generally not sufficient for treating severe infections or septic shock due to its narrower spectrum of activity compared to Piperacillin-Tazobactam.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ceftriaxone:</span></strong><span style=\"font-size:12.0pt\"> While Ceftriaxone is a third-generation cephalosporin, it is not as broad-spectrum as Ceftazidime and does not provide the same coverage needed for septic shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nitrofurantoin:</span></strong><span style=\"font-size:12.0pt\"> This antibiotic is typically used for uncomplicated lower urinary tract infections and is not effective for severe systemic infections or septic shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the management of septic shock, especially in a patient with diabetes and complicated UTI, broad-spectrum antibiotics such as Piperacillin-Tazobactam are critical for empirical therapy.</span></span></span></p>",
      "correct_choice_id": 47517,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52812,
      "choices": [
        {
          "id": 210737,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ankylosing spondylitis</span></span></span></p>"
        },
        {
          "id": 210738,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Paget&#39;s disease</span></span></span></p>"
        },
        {
          "id": 210739,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Healed tuberculosis</span></span></span></p>"
        },
        {
          "id": 210740,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteopetrosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young man came to the medical OPD with complaints of early morning backache and stiffness, which improves on exercise, and persistent red eyes. On examination, lung expansion was less than 3 cm. X-ray is shown in the image given below. What is the most probable diagnosis? (NEET PG 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170601.jpg\" style=\"height:363px; width:276px\" /></span></span></span></p>",
      "unique_key": "Q9181986",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012794,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Ankylosing spondylitis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints, leading to pain and stiffness. The hallmark feature of AS is inflammatory back pain, which is characterized by pain and stiffness that are worse in the morning and improve with exercise. The persistent red eyes are indicative of anterior uveitis, a common extra-articular manifestation of AS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The reduced lung expansion (less than 3 cm) points towards involvement of the thoracic spine, leading to restrictive lung disease due to reduced chest wall mobility. The X-ray image shows characteristic changes of AS, including syndesmophytes and the &quot;<strong>bamboo spine&quot; appearance</strong>, which result from the ossification of ligaments and entheses (where tendons and ligaments attach to the bone).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-31-120619.jpg\" style=\"height:475px; width:300px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bamboo spine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Paget&#39;s disease:</span></strong><span style=\"font-size:12.0pt\"> This condition is characterized by abnormal bone remodeling but does not typically present with inflammatory back pain or extra-articular manifestations such as uveitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Healed</span></strong><span style=\"font-size:12.0pt\"> <strong>tuberculosis:</strong> While tuberculosis can affect the spine (Pott&#39;s disease), it does not present with the classic inflammatory back pain or the characteristic radiographic changes seen in AS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Osteopetrosis:</span></strong><span style=\"font-size:12.0pt\"> This is a rare genetic disorder that leads to increased bone density and brittleness but does not present with the clinical and radiographic features of AS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ankylosing spondylitis should be suspected in young patients with inflammatory back pain that improves with exercise, reduced lung expansion, and extra-articular manifestations such as uveitis. The &quot;bamboo spine&quot; on X-ray is a characteristic finding in advanced cases of AS.</span></span></p>",
      "correct_choice_id": 210737,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16296,
      "choices": [
        {
          "id": 65144,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bundle branch block</span></span></span></p>"
        },
        {
          "id": 65145,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute MI</span></span></span></p>"
        },
        {
          "id": 65146,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyperkalemia</span></span></span></p>"
        },
        {
          "id": 65147,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventricular ectopic</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tall and tented T waves, wide QRS, and absent P wave are features of:&nbsp;(FMGE DEC 2021)</span></span></span></p>",
      "unique_key": "Q8648706",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012795,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Hyperkalemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tall, tented T waves, wide QRS complexes, and absent P waves are classic ECG findings in hyperkalemia, which indicate a high level of potassium in the blood. Hyperkalemia affects the electrical activity of the heart, leading to these characteristic changes on the ECG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Bundle branch block</span></strong><span style=\"font-size:12.0pt\">: Characterized by a widened QRS but does not typically present with tall T waves or absent P waves.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Acute MI</span></strong><span style=\"font-size:12.0pt\">: May show ST elevation or other changes, but not specifically tall T waves and wide QRS without P waves.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ventricular ectopic</span></strong><span style=\"font-size:12.0pt\">: Characterized by premature ventricular contractions, not the described ECG findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyperkalemia shows tall T waves, wide QRS complexes, and absent P waves on ECG.</span></span></span></p>",
      "correct_choice_id": 65146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47612,
      "choices": [
        {
          "id": 190059,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary adenoma</span></p>"
        },
        {
          "id": 190060,
          "text": "<p><span style=\"font-size:12.0pt;\">Ectopic ACTH producing tumor</span></p>"
        },
        {
          "id": 190061,
          "text": "<p><span style=\"font-size:12.0pt;\">Exogenous source</span></p>"
        },
        {
          "id": 190062,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal adenoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A chronic smoker presents with weight gain and hyperpigmentation. High dose dexamethasone suppression test was done in a patient &amp; ACTH remained high before and after the test. What is the likely diagnosis?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q3510369",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012773,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ectopic ACTH producing tumor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is a chronic smoker, which increases the risk of cancers such as small cell lung cancer, known to produce ectopic ACTH. The presentation of weight gain and hyperpigmentation are features of Cushing's syndrome. In ectopic ACTH production, the high-dose dexamethasone suppression test typically fails to suppress ACTH levels, as observed in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pituitary adenoma:&nbsp;</strong>In Cushing's disease caused by a pituitary adenoma, ACTH levels usually decrease with high-dose dexamethasone suppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Exogenous source:&nbsp;</strong>Exogenous steroids do not cause hyperpigmentation and would suppress ACTH levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Adrenal adenoma:&nbsp;</strong>In adrenal adenoma, cortisol levels are high, which suppresses ACTH production, leading to low ACTH levels and no hyperpigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ectopic ACTH production, often from small cell lung cancer, should be suspected in chronic smokers presenting with features of Cushing's syndrome and non-suppressible ACTH levels following high-dose dexamethasone suppression test. ​</span></p>",
      "correct_choice_id": 190060,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11361,
      "choices": [
        {
          "id": 45410,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spontaneous bacterial peritonitis</span></span></span></p>"
        },
        {
          "id": 45411,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malignant ascites</span></span></span></p>"
        },
        {
          "id": 45412,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tubercular ascites</span></span></span></p>"
        },
        {
          "id": 45413,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intestinal obstruction</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with a history of chronic liver disease presents with abdominal distension, jaundice, and pruritis. Ascitic fluid analysis revealed a neutrophil count &gt; 650 per cubic mm. What is the most likely diagnosis? (Neet pg 2022)</span></span></span></p>",
      "unique_key": "Q6246600",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012793,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A)</span></strong><strong><span style=\"font-size:12.0pt\">&nbsp;Spontaneous bacterial peritonitis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spontaneous bacterial peritonitis (SBP) is a common and serious complication in patients with chronic liver disease and ascites. It is diagnosed when the ascitic fluid neutrophil count exceeds 250 cells/mm3. In this case, the neutrophil count is significantly higher than the threshold, indicating a strong likelihood of SBP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chronic Liver Disease Symptoms</span></strong><span style=\"font-size:12.0pt\">: The patient presents with symptoms typical of chronic liver disease, including abdominal distension, jaundice, and pruritis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Neutrophil Count</span></strong><span style=\"font-size:12.0pt\">: An ascitic fluid neutrophil count &gt; 250 cells/mm3&nbsp;is diagnostic of SBP. This patient&#39;s count of &gt; 650 cells/mm3 strongly supports this diagnosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Management</span></strong><span style=\"font-size:12.0pt\">: Immediate antibiotic therapy is crucial for SBP. Standard treatment involves third-generation cephalosporins like cefotaxime or ceftriaxone. In areas with high resistance to these antibiotics, piperacillin-tazobactam used in India.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Malignant Ascites:</span></strong><span style=\"font-size:12.0pt\"> Malignant ascites is associated with peritoneal carcinomatosis or other cancers. The neutrophil count in ascitic fluid in such cases is generally lower, and the fluid is often exudative rather than the neutrophil-predominant fluid seen in SBP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tubercular Ascites:</span></strong><span style=\"font-size:12.0pt\"> Tubercular ascites usually presents with a lymphocyte-predominant fluid rather than neutrophil-predominant. It is also associated with other findings such as a high protein content and a positive acid-fast bacilli smear.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Intestinal Obstruction:</span></strong><span style=\"font-size:12.0pt\"> Intestinal obstruction may lead to ascites, but the fluid analysis would not typically show a high neutrophil count. The clinical presentation and history would also differ significantly, focusing more on obstructive symptoms like severe pain, vomiting, and constipation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spontaneous bacterial peritonitis should be suspected in patients with chronic liver disease and ascites if the ascitic fluid neutrophil count exceeds 250 cells/mm3, necessitating prompt antibiotic treatment.</span></span></p>",
      "correct_choice_id": 45410,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49086,
      "choices": [
        {
          "id": 195919,
          "text": "<p><span style=\"font-size:12.0pt;\">Predominant symptom is dyspnea</span></p>"
        },
        {
          "id": 195920,
          "text": "<p><span style=\"font-size:12.0pt;\">Also known as \"\"blue bloaters\"\"</span></p>"
        },
        {
          "id": 195921,
          "text": "<p><span style=\"font-size:12.0pt;\">DLCO is normal</span></p>"
        },
        {
          "id": 195922,
          "text": "<p><span style=\"font-size:12.0pt;\">Patients are usually obese</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are true about chronic bronchitis, except:(NEET PG 2017)</span></p>",
      "unique_key": "Q5780094",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012788,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. A) Predominant symptom is dyspnea</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>The predominant symptom in chronic bronchitis is productive cough, not dyspnea. Chronic bronchitis typically presents with productive cough and minimal shortness of breath. This contrasts with emphysema, where severe dyspnea is the primary complaint with only mild cough.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Also known as \"blue bloaters\"</strong>: This is correct. Patients with chronic bronchitis are known as \"blue bloaters\" due to their clinical presentation with cyanosis and fluid retention. This is a classic description used to distinguish them from emphysema patients who are termed \"pink puffers.\"</p><p>&nbsp;</p><p><strong>Option C. DLCO is normal</strong>: This is correct. In chronic bronchitis, diffusing capacity (DLCO) is typically normal, unlike in emphysema where DLCO is reduced due to destruction of the alveolar-capillary interface.</p><p>&nbsp;</p><p><strong>Option D. Patients are usually obese</strong>: This is correct. The typical body habitus of chronic bronchitis patients is obese, in contrast to emphysema patients who tend to be cachectic. This physical appearance difference is part of the classical clinical distinction between these two COPD phenotypes.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Chronic bronchitis presents primarily with productive cough rather than dyspnea, and patients are typically obese \"blue bloaters\" with normal DLCO values, in contrast to emphysema patients who present primarily with dyspnea.</p>",
      "correct_choice_id": 195919,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11295,
      "choices": [
        {
          "id": 45146,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2-3 L of normal saline over 1-3 hours</span></span></p>"
        },
        {
          "id": 45147,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin infusion at 0.1 units/kg/hour</span></span></p>"
        },
        {
          "id": 45148,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arterial blood gas</span></span></p>"
        },
        {
          "id": 45149,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin bolus of 0.1 units/kg given IV</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old child who is known to have type 1 diabetes mellitus presents with confusion and drowsiness. Her mother says that she seems to be breathing very fast. On examination, mucous membranes are dry and blood pressure is 70/50 mm Hg. Random blood glucose is 415 mg/dL and urine ketones are 4+. What is the next best step in management? (NEET PG 2020)</span></span></p>",
      "unique_key": "Q2400871",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012791,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. 2-3 L of Normal saline over 1-3 hours </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV fluids are the next best management as the patient is in shock and needs immediate correction. <strong>ABG here could show HAGMA</strong> <strong>secondary to type A lactic acidosis</strong> or ketoacidosis. Hence, ABG wouldn&rsquo;t help in the diagnosis here. <strong>Shock in patient with DKA is not common</strong> and suggest an underlying sepsis as excess glucotoxicity causes shift of H<sub>2</sub>O to the intravascular compartment. IV fluid bolus is given in the emergency immediately.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Insulin infusion at 0.1 units/kg/hour:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While insulin therapy is critical in the management of DKA, it should only be started after initial fluid resuscitation has been commenced and any electrolyte imbalances, particularly potassium, have been assessed and addressed.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Arterial blood gas:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While ABG can provide valuable information about the severity of acidosis and help guide management, it is not the immediate next step before ensuring adequate fluid resuscitation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Insulin bolus of 0.1 units/kg given IV:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An insulin bolus can potentially exacerbate hypokalemia in the setting of DKA. Fluid resuscitation and stabilization should precede any insulin bolus or infusion.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a case of DKA presenting with signs of dehydration and shock, the initial management should focus on aggressive fluid resuscitation to stabilize the patient before initiating insulin therapy. This approach not only addresses the immediate life-threatening condition but also prepares the body for further metabolic correction.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21E/DKA/Chapter 404</span></span></strong></p>",
      "correct_choice_id": 45146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11220,
      "choices": [
        {
          "id": 44846,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV DNA PCR</span></p>"
        },
        {
          "id": 44847,
          "text": "<p><span style=\"font-size:12.0pt;\">Cord blood ELISA</span></p>"
        },
        {
          "id": 44848,
          "text": "<p><span style=\"font-size:12.0pt;\">Western blot</span></p>"
        },
        {
          "id": 44849,
          "text": "<p><span style=\"font-size:12.0pt;\">Third generation ELISA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the diagnostic test of choice for HIV in a baby born to an HIV-infected mother?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q3955261",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012866,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. HIV DNA PCR</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Maternal antibodies transferred passively to the infant may persist 9-18 months and hence ELISA/antibody tests positivity would indicate possible exposure to HIV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Currently NACO recommends&nbsp;<strong>HIV-TNA PCR (Total nucleic acid = pro-viral DNA + RNA)</strong> which has <strong>Sensitivity of 99% and Specificity of 98% in infants &lt; 18 months of age</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>DBS (Dried blood sample) is recommended</strong> and not CORD BLOOD (as it contains maternal blood contamination).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>Western blot is not recommended by NACO for the diagnosis of HIV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>ELISA based test <strong>detects antibodies</strong>, however, maternal transmission occurs in infants trans placentally and hence cannot help in diagnosis of active disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For infants born to HIV-infected mothers, HIV DNA PCR is the preferred diagnostic test because it detects viral DNA directly, avoiding the pitfalls of tests that detect antibodies, which may not distinguish between maternal antibodies and those produced by the infant itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: NACO 2021 HIV Care and treatment guidelines Page 185</strong></span></p>",
      "correct_choice_id": 44846,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47547,
      "choices": [
        {
          "id": 189799,
          "text": "<p><span style=\"font-size:12.0pt;\">Arthritis</span></p>"
        },
        {
          "id": 189800,
          "text": "<p><span style=\"font-size:12.0pt;\">Chorea</span></p>"
        },
        {
          "id": 189801,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythema marginatum</span></p>"
        },
        {
          "id": 189802,
          "text": "<p><span style=\"font-size:12.0pt;\">Subcutaneous nodules</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with a pansystolic murmur and features of carditis. Echocardiography showed mitral regurgitation. Which of the following is the most common manifestation of this condition?</span></p>",
      "unique_key": "Q1690981",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012772,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Arthritis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation <strong>suggests acute rheumatic fever (ARF)</strong>, which often presents with carditis as one of the major manifestations. In ARF, the most common manifestation is <strong>arthritis</strong>, which is typically a <strong>migratory</strong> <strong>polyarthritis</strong> affecting large joints such as the knees, ankles, elbows, and wrists. This arthritis responds well to nonsteroidal anti-inflammatory drugs (NSAIDs).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Chorea:&nbsp;</strong>This is also a manifestation of ARF but is less common than arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Erythema marginatum:&nbsp;</strong>This is a characteristic rash seen in ARF but is less common than arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Subcutaneous nodules:&nbsp;</strong>These are also seen in ARF but are much less common than arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In acute rheumatic fever, arthritis is the most common manifestation, typically presenting as migratory polyarthritis that responds well to NSAIDs.</span></p>",
      "correct_choice_id": 189799,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84277,
      "choices": [
        {
          "id": 335688,
          "text": "<p><span style=\"font-size:12.0pt;\">Small ASD</span></p>"
        },
        {
          "id": 335689,
          "text": "<p><span style=\"font-size:12.0pt;\">Small VSD</span></p>"
        },
        {
          "id": 335690,
          "text": "<p><span style=\"font-size:12.0pt;\">Mild MR</span></p>"
        },
        {
          "id": 335691,
          "text": "<p><span style=\"font-size:12.0pt;\">Mild TR</span></p>"
        }
      ],
      "text": "<p>Which of the following conditions is least likely to be associated with Infective Endocarditis? (NEET PG 2016)</p>",
      "unique_key": "Q3768064",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012864,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. A) Small ASD.</strong></p><p>&nbsp;</p><p>Isolated atrial septal defect (ASD) is specifically excluded from cardiac conditions predisposing to infective endocarditis. When evaluating endocarditis risk factors, conditions that create turbulent blood flow with high-velocity jets are most concerning, as they damage endothelial surfaces and provide locations for bacterial adherence. Small ASDs typically create minimal hemodynamic disturbance and lack the significant turbulent flow pattern that promotes vegetation formation.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Small VSD</strong>: Ventricular septal defects, even small ones, create abnormal blood flow patterns with higher-velocity jets that can damage endothelium, creating a nidus for bacterial adherence. While repaired VSDs have lower risk, unrepaired VSDs remain a predisposing condition for endocarditis.</p><p>&nbsp;</p><p><strong>Option C. Mild MR</strong>: Mitral regurgitation represents a valvular abnormality with regurgitant flow that predisposes to endocarditis. The turbulent flow across the abnormal valve creates conditions favorable for bacterial adherence and vegetation formation, even when the regurgitation is mild.</p><p>&nbsp;</p><p><strong>Option D. Mild TR</strong>: Tricuspid regurgitation, like mitral regurgitation, creates turbulent flow patterns that can damage endothelium and facilitate bacterial adhesion. Valvular regurgitation at any valve is a recognized risk factor for infectious endocarditis.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>While most valvular and structural cardiac abnormalities increase endocarditis risk through turbulent flow patterns, isolated atrial septal defect stands as a notable exception, carrying minimal risk for infective endocarditis.</p>",
      "correct_choice_id": 335688,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55354,
      "choices": [
        {
          "id": 220877,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Metabolic acidosis</span></span></p>"
        },
        {
          "id": 220878,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Metabolic alkalosis</span></span></p>"
        },
        {
          "id": 220879,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Respiratory acidosis</span></span></p>"
        },
        {
          "id": 220880,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Respiratory alkalosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Which of the following best describes the ABG findings: (FMGE JULY 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">pH &ndash; 7.28,</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">PaCO2 &ndash; 28 mm Hg, </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">PaO2 &ndash; 98 mm Hg, </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Na &ndash; 140 mEq/L, </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">K &ndash; 4.9 mEq/L, </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">HCO3 &ndash; 14 mEq/L, </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cl &ndash; 100 mEq/L.</span></span></p>",
      "unique_key": "Q3757116",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012800,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Metabolic acidosis</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The ABG (arterial blood gas) findings indicate a pH of 7.28, which is below the normal range (7.35-7.45), indicating acidosis. Both PaCO2 and HCO3 are low, which suggests a primary metabolic issue. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">According to the <strong>mnemonic &quot;ROME&quot; (Respiratory Opposite, Metabolic Equal),</strong> in metabolic disorders, the pH and bicarbonate move in the same direction. Here, both pH and HCO3 are low, confirming metabolic acidosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Additionally, calculating the anion gap helps further classify the metabolic acidosis. The anion gap is calculated as Na - (HCO3 + Cl) = 140 - (14 + 100) = 26, which is above the normal range (8-12 mEq/L), indicating a high anion gap metabolic acidosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Metabolic alkalosis: </strong>This condition is characterized by an increased pH (alkalosis) and increased HCO3. The patient&#39;s pH is low, not high, ruling out metabolic alkalosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Respiratory acidosis: </strong>This condition is characterized by a decreased pH (acidosis) and increased PaCO2 due to hypoventilation. The patient&#39;s PaCO2 is low, not high, ruling out respiratory acidosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Respiratory alkalosis: </strong>This condition is characterized by an increased pH (alkalosis) and decreased PaCO2 due to hyperventilation. The patient&#39;s pH is low, indicating acidosis, not alkalosis, ruling out respiratory alkalosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Metabolic acidosis is indicated by a low pH and low HCO3, with the same direction of changes in both parameters. A high anion gap indicates the presence of unmeasured anions, often seen in conditions like diabetic ketoacidosis, lactic acidosis, and renal failure.</span></span></p>",
      "correct_choice_id": 220877,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11261,
      "choices": [
        {
          "id": 45010,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MR</span></span></span></span></p>"
        },
        {
          "id": 45011,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HOCM</span></span></span></span></p>"
        },
        {
          "id": 45012,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VSD</span></span></span></span></p>"
        },
        {
          "id": 45013,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MS</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following murmur increases on standing? (NEET PG 2019)</span></span></p>",
      "unique_key": "Q9140682",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012867,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. HOCM</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The murmur of Hypertrophic Obstructive Cardiomyopathy (HOCM) typically increases on standing. This is due to the decreased venous return and preload that occur with standing, which result in a reduction in the size of the left ventricular cavity. The smaller cavity size exacerbates the outflow obstruction under the aortic valve, thereby intensifying the murmur.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Mitral Regurgitation (MR):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The murmur associated with MR typically decreases when standing due to the decreased venous return and reduced volume load on the left ventricle, which lessens the regurgitant flow across the mitral valve.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ventricular Septal Defect (VSD):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The murmur of a VSD generally decreases on standing due to reduced left to right shunting caused by decreased venous return.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Mitral Stenosis (MS):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The murmur of mitral stenosis also decreases on standing. The reduction in preload lessens the flow through the narrowed mitral valve, subsequently reducing the intensity of the murmur.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the options listed, the murmur of Hypertrophic Obstructive Cardiomyopathy is unique in that it increases on standing, due to the specific hemodynamic changes that accentuate the outflow obstruction. This characteristic can be a crucial diagnostic clue in the clinical assessment of murmurs.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Physical examination of CVS/Chap 239</span></span></strong></p>",
      "correct_choice_id": 45011,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 46975,
      "choices": [
        {
          "id": 187515,
          "text": "<p>The white matter</p>"
        },
        {
          "id": 187516,
          "text": "<p>The gray matter</p>"
        },
        {
          "id": 187517,
          "text": "<p>Both the white and gray matter</p>"
        },
        {
          "id": 187518,
          "text": "<p>Neither the white nor the gray matter</p>"
        }
      ],
      "text": "<p>Binswanger's disease, a form of vascular dementia, primarily affects which part of the brain?&nbsp;(NEET PG 2015)</p>",
      "unique_key": "Q8216548",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012786,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: A. The white matter</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Binswanger's disease, also known as subcortical arteriosclerotic encephalopathy, is a prototypical clinical syndrome of vascular cognitive impairment that primarily affects the white matter of the brain. The condition is characterized by progressive confluent subcortical and periventricular white matter disease visible on neuroimaging, with hypoperfusion and hypometabolism. Pathologically, it involves extensive demyelination and destruction of white matter with relative sparing of the subcortical U fibers. Patients typically present with hypertension or systemic vascular disease, and may develop gradual accumulation of focal neurological deficits along with cognitive dysfunction.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. The gray matter:</strong> Binswanger's disease specifically targets white matter rather than gray matter. Gray matter disorders typically present with different clinical patterns, such as cortical symptoms including aphasia, agnosia, or apraxia, which are not characteristic of Binswanger's disease.</p><p>&nbsp;</p><p><strong>Option C. Both the white and gray matter:</strong> While some vascular dementias can affect both white and gray matter, Binswanger's disease is defined by its predominant impact on white matter. The pathology shows selective destruction of white matter with relative preservation of gray matter structures.</p><p>&nbsp;</p><p><strong>Option D. Neither the white nor the gray matter:</strong> This is incorrect as Binswanger's disease definitively affects brain tissue, specifically the white matter regions. It is not a disease of other tissues such as blood vessels alone or non-neural brain components.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Binswanger's disease is a subcortical vascular dementia characterized by progressive white matter destruction due to small vessel disease, resulting in a dysexecutive syndrome with apathy, mood alterations, executive dysfunction, and slowed information processing.</p>",
      "correct_choice_id": 187515,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50970,
      "choices": [
        {
          "id": 203421,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At least 80g dietary fibre&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203422,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;5 g salt intake everyday&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203423,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt; 30% of the calories should come from fat&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203424,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholesterol &lt; 100g&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A diabetic patient&#39;s fasting blood glucose level is found to be 160 mg/dL. What will you advise the patient regarding non-pharmacological management? (</span></span>INICET Nov 2023)</p>",
      "unique_key": "Q1297248",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012856,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) &lt; 30% of the calories should come from fat</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When advising a diabetic patient on non-pharmacological management, it is essential to focus on dietary and lifestyle modifications that can help control blood glucose levels and reduce cardiovascular risk. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is advisable for less than 30% of daily caloric intake to come from fat, with saturated fat being less than 10% and avoiding trans fats altogether. This recommendation helps in managing cholesterol levels and reducing cardiovascular risk.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>At least 80g dietary fibre:</strong> The recommended daily intake of dietary fiber is 25 to 40 grams, not 80 grams. High fiber intake helps in controlling blood sugar levels.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>&lt;5 g salt intake everyday</strong>: The recommendation for sodium intake is less than 2.3 grams per day, with overall salt intake being less than 5 grams per day.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; &nbsp;&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Cholesterol &lt; 100g:</strong> There is no guideline recommending cholesterol intake to be less than 100 grams. Current guidelines focus more on overall fat intake and the types of fats consumed rather than specific cholesterol limits.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For diabetic patients, it is recommended that less than 30% of daily calories come from fat, with saturated fat being less than 10% and trans fats being avoided. This helps in managing blood sugar levels and reducing cardiovascular risks.</span></span></p>",
      "correct_choice_id": 203423,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50969,
      "choices": [
        {
          "id": 203417,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignancy&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203418,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary hyperparathyroidism&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203419,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D toxicity&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203420,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypocalciuric hypercalcemia&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common cause of hypercalcemia in hospitalized patients is (</span></span>INICET Nov 2023</p>",
      "unique_key": "Q4274848",
      "question_audio": null,
      "question_video": null,
      "map_id": 35012779,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Malignancy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: &nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In hospitalized patients, the most common cause of hypercalcemia is malignancy. Malignancy-associated hypercalcemia often results from the secretion of parathyroid hormone-related peptide (PTHrP) by cancer cells, which mimics the effects of parathyroid hormone, leading to increased calcium levels. This is frequently seen in cancers such as breast cancer, lung cancer, and multiple myeloma.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Primary hyperparathyroidism:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the most common cause of hypercalcemia in outpatients but not in hospitalized patients. It is characterized by elevated levels of parathyroid hormone (PTH) due to parathyroid gland hyperplasia, adenoma, or carcinoma.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vitamin D toxicity:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypercalcemia can occur due to excessive intake of vitamin D, leading to increased intestinal absorption of calcium. However, it is not the most common cause in hospitalized patients.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Familial hypocalciuric hypercalcemia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a rare genetic condition characterized by benign hypercalcemia with low urinary calcium excretion. It mimics primary hyperparathyroidism but is less common and typically not seen as the most frequent cause of hypercalcemia in hospitalized patients.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignancy is the most common cause of hypercalcemia in hospitalized patients, often due to the secretion of PTHrP by cancer cells.</span></span></span></span></p>",
      "correct_choice_id": 203417,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}